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ABSTRACT 
 
Adherence to health behaviors is essential to achieve successful TB 
treatment. This study aimed to examine the effect of a family-based DOTS support 
program on adherence to health behaviors in patients with pulmonary TB. The 
program was designed using Orem’s Self-Care Deficit Nursing Theory. 
Sixty TB patients and their families were selected using cluster 
randomization of community health centers. The subjects were assigned into a control 
group, who received the routine care, and an experimental group, who received both 
routine care and care from the family-based DOTS support program. The program 
was operated by taking a patient’s family as a nursing client. Four major methods – 
teaching, guiding, supporting, and providing environment – were used throughout the 
program’s implementation to develop system of care. Three components of care 
operations were enhanced: 1) estimative operation: helped the clients to gain 
understanding on TB overview, TB & medications/ diet/ exercise/ environment/ 
transmission/ risk factors using teaching techniques; 2) transitive operation: assisted 
the clients’ decisions on care activities by providing choices and discussing their 
benefits and limitations; and 3) productive operation: encouraged the clients to make 
action plans to care for the patients. The follow-ups included two telephone follow-
ups and a face-to-face meeting. The TB care booklet was used to enhance the learning 
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about care within the family context among the patients and their families. The pretest 
and post-test data were collected at two points in time, five weeks apart, using 
adherence to health behaviors questionnaire that had Cronbach’s alpha of .78 and had 
been validated by three experts. Paired t-test was used to assess changes within the 
group while the independent t-test was applied to determine the difference between 
two groups. Additionally, ANCOVA was employed to examine the effectiveness of 
the program by adjusting the covariates. 
The total score of adherence to health behaviors in the experimental 
group was significantly higher after receiving care from the family-based DOTS 
support program than the pretest score, (t = -10.34, p < .001). In addition, after 
adjusting length of treatment and joint pain as the covariates, the adherence to health 
behaviors in the experimental group significantly improved on the fifth week 
compared to those of the control group (p < .001). 
 This study recommended that the family-based DOTS support program 
could enhance adherence to health behaviors among patients with pulmonary TB. 
Suggestions were made to expand the application of this program in various contexts 
and to extend knowledge for nursing practices and research.   
 
Keywords: Self-Care Deficit Nursing Theory, family-based DOTS program, 
pulmonary Tuberculosis, adherence, health behaviors, 
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CHAPTER 1 
INTRODUCTION 
 
  This chapter details the study’s background significance, objectives, 
research questions, theoretical framework, hypotheses, definitions of terms and 
significance. 
 
Background and Significance of the Problem 
  Tuberculosis (TB) persists as a public health burden worldwide and is 
one of the leading causes of death by infectious diseases (World Health Organization 
[WHO], 2010a). In 2009, WHO has updated mortality rate (excluding Human 
Immunodeficiency Virus [HIV]) to be approximately 20 per 100,000 people globally. 
In addition, the incidence and the prevalence of TB worldwide were estimated at 140 
per 100,000 people and 164 per 100,000 people, respectively (WHO). Global 
prevalence and incidence rates have been declining, except in South-East Asia region, 
where incidence rate has been stable (WHO).  
  Indonesia is one of five countries in the world with the largest number 
of TB incidences in 2009 (WHO, 2010a), with rates of mortality, incidence, and 
prevalence recorded at 27 per 100,000 people, 189 per 100,000 people, and 285 per 
100,000 people, respectively (WHO). Unfortunately, Indonesia’s TB data and most 
high-burden countries’ do not include high-quality data for mortality rate (Mathers, 
Fat, Inoue, Rao, & Lopez, 2005). Although the multi-drug resistant (MDR) rate in 
Indonesia is lower than the estimated South Asian region’s average of 4%, preventive 
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actions should still continue (WHO, 2009a). Nonetheless, the HIV/ AIDS epidemic 
has made it difficult to control TB in many countries including Indonesia (WHO, 
2006).  
  TB is treatable by a 6-month drug regimen. Therefore, treatment plays 
important roles for TB patients, from curing the disease, restoring quality of life and 
productivity, preventing death and even possible relapses, reducing transmission of 
TB to others, to preventing drug resistance (WHO, 2009b). However, the treatment 
could prove to be challenging, for both patients and health providers, as patients are 
required to take multiple medications for a minimum of 6 months (American Thoracic 
Society [ATS] and Centers for Disease Control [CDC] as cited in Jasmer et al., 2004). 
Failure of TB treatment often occurs due to patients not adhering to the drug regimen 
(the most common reason), extensive cavitary disease at the time of diagnosis, drug 
resistance, malabsorption of drugs, laboratory error and biological variation in 
response (ATS, CDC, Infectious Diseases Society of America, 2003). Patients are 
often not adhering to the drug regimen due to symptomatic improvement (McInerney 
et al., 2007), co-morbidity (Ai et al., 2010), reaction to side effects (Ai et al., 2010; 
Munro et al., 2007; Xu et al., 2009) and feeling better (Cramm, Finkenflügel, Møller, 
& Nieboer, 2010; Kaona, Tuba, Siziya, & Sikaona, 2004). Therefore, the key success 
of treatment requires maintenance of patient’s health, including healthy behaviors and 
taking medications. 
  To achieve successful TB treatment, the patients must adhere to the TB 
drug regimen. However, effective TB treatment also requires the patients to follow 
healthy behaviors. TB is strongly correlated to poverty, malnutrition, overcrowding, 
sub-standard housing, and inadequate health care (Smeltzer & Bare, 2003). Villamor 
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et al (2008) stated that TB patients are often deficient in micronutrients: vitamins A, 
C, and E, the B vitamins, and selenium. Supplementing micronutrient is thus 
correlated with lower rate of TB treatment failure (Villamor et al., 2008). 
Overcrowded housings, which tend to be associated with poor socioeconomic status, 
is also an important factor (Schmidt, 2008). Howden-Chapman (2004) found that 
overcrowding is linked with higher rates of infectious diseases. TB spreads through 
talking, sneezing, or coughing so the patients must prevent the disease transmission. 
Smoking is also closely connected with TB; TB patients are more likely to be smokers 
(Gajalaksmi et al., as cited in Siddiqi & Keng, 2009). Changing these behaviors thus 
influences the results of TB treatment. 
  Adherence to health behaviors is essential to successful TB treatment, 
particularly increasing the chance of cure, decreasing the risk of relapse after 
treatment, and minimizing drug resistance (Maartens & Wilkinson, 2007). WHO 
(2003) defined adherence as the extent to which the patient follows medical 
instructions. Most research merely concerned adherence to medication (Martins, 
Grace, & Kelly, 2008; Li, Munsiff, Tarantion, & Dorsinville, 2010; McInerney et al., 
2007; Trajman et al., 2010) but adherence also includes health-promoting behaviors 
that extend beyond complying to the medical regimen. For example, the definition of 
long-term adherence is “the extent to which a person’s behavior – taking medication, 
following a diet, and/or executing lifestyle changes – corresponds with agreed 
recommendations from a health care provider” (WHO, 2003, p.4). Biswas (2010) 
included the following health behaviors in her study: complying with anti-TB 
medication, following healthy diets, performing physical exercise, maintaining 
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environmental hygiene, preventing disease transmission, and avoiding the risk factors 
of TB.  
  Adherence to health behaviors is one concern that affects TB control. 
Poor adherence is recognized as a major cause of treatment failure, relapse and drug 
resistance (WHO, 2003). The effectiveness of TB control will be improved by high 
rate of adherence (Long as cited in Li, Munsiff, Tarantion, & Dorsinville, 2010). 
Therefore, certain health behaviors such as treatment adherence and other 
contributing behaviors can predict the treatment completion (Trajman et al., 2010). 
Pursuing high-quality, directly observed treatment short-course 
(DOTS) expansion and enhancement has a pivotal role in promoting TB treatment 
(WHO, 2006). Success of DOTS can be seen from the treatment outcomes, measured 
at 90 % success rate, which included rate of cure and completion of treatment, and at 
70% detection rate (WHO, 2009b, 2010a). Data showed that 41 millions of TB 
patients were successfully treated in DOTS programs and up to 6 million lives, 
including 2 million women and children between 1995 and 2009, were saved (WHO, 
2010a, 2010c). Indonesia had 67% of case detection rate and 91% of treatment 
success rate among the cohort of patients registered in 2008 (WHO, 2011).  
DOTS facilitates the success TB management through treatment 
adherence and health-related behaviors. One method that helps ensure the adherence 
to health behaviors is identifying directly observed treatment (DOT) supporters for 
each TB patient. These supporters can be a healthcare provider, a family member, and 
a community health volunteer. Sanchez and Bertolozzi (2009) stated that limited 
number of health care providers and resources to meet patients’ needs are obstacles of 
DOTS implementation. 
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However, it is worth noting that an effect of each DOT supporter on 
the final outcomes has shown varying, and in some cases conflicting results. The TB 
patients who were observed by health care providers (HCP) and family members 
(FM) had more success in two months and again at the end of TB treatment course 
than those who were self-administered (SA) (Anuwatnonthakate et al., 2008; 
Mathema et al., 2001). Other studies found that FM DOT helped achieved higher 
success rate than health care volunteer (HCV) DOT (Maciel, Guidoni et al., 2010; 
Okanurak, Kitayaporn, Wanarangsikul, & Koompong, 2007). Furthermore, FM is 
better than SA in achieving success rate of TB treatment (MacIntyre et al., 2003). 
Conversely, a review from Volmink and Garner (2007) found that there was no 
significant difference of cured rate of TB treatment between the patients who 
observed by DOT (HCP, FM, & HCV) and those who were SA. In addition, there was 
also no significant difference in clinical outcomes between DOT by HCP, FM, and 
HCV. This finding is similar with the studies of MacIntyre et al. (2003), Walley et al. 
(2001) and Wright et al. (2004). Regarding to the unsuccessful using FM DOT may 
cause unwell prepare the family to gain ability to care for the patient. 
  A family member can serve as a DOTS supporter for the TB patients. 
Nasution (2007) found that a group of patients who were successful in complying 
with DOTS received more family support than those who were unsuccessful in 
complying with DOTS in Medan, Indonesia. Family support is therefore associated 
with health behaviors in TB patients. Biswas (2010) found that there was a 
statistically and significantly positive correlation between health behaviors and family 
support among patients with pulmonary TB. Frieden and Sbarbaro (2007) stated that 
treatment observation must be performed by a person who is accessible to and 
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accepted by the patient, therefore, a family member is the most suitable. Pungrassami, 
Johnsen, Chongsuvivatwong, Olsen, & Sørensen (2002) indicated that family bonds 
have more benefits in terms of general care and psychological support. Therefore, 
family participation during TB treatment will help encourage a patient adhere to 
health behaviors and as a result achieve successful treatment. 
  The topic of using family members as DOT supporters have been 
studied in both developed and developing countries. However, these studies are 
dominated by epidemiological research. Though nursing research exists, none has 
been conducted in Indonesia. The self-care deficit nursing theory (SCDNT) provides a 
structure to help examine the meaning of family from a nursing perspective (Taylor, 
2001).  For this reason, Orem’s SCDNT will be used as a theoretical framework in 
this study, particularly dependent care agency, where supports to TB patients are 
provided by family along with supportive educative nursing system. Helping methods, 
which refer to teaching, guiding, supporting, and providing environment (Orem, 1995, 
2001), will be used to increase adherence to health behaviors among pulmonary TB 
patients.  
  Supportive educative program has been used in diabetic patients and 
the results showed that the mean of total self care practices and the mean of each sub 
variables – dietary control, exercise, medication, exercise, stress management, and 
personal hygiene – were significantly higher than standard care group in Malaysia 
(Mohamed, 2005). Similarly, this program had positive effects on self-care practices 
for chronic obstructive pulmonary disease (COPD) patients (Kamsee, 2004) as well as 
knowledge level, self-efficacy expectation, and self-care behaviors among TB 
prisoners in Thailand (Ngamtrairai, 2003). Consequently, the researcher would like to 
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test the effect of a family-based DOTS support program on TB patients’ adherence to 
health behaviors. The findings of this study will provide evidence regarding the 
practice of family-based DOTS support program in Indonesia and, hopefully, the 
program will be used as a guideline to provide care for TB patients at home. 
 
Objectives of the Study 
  The objectives of this study are as follow: 
1. To compare adherence to health behaviors of pulmonary TB 
patients before and after receiving family-based DOTS support 
program. 
2. To compare adherence to health behaviors of pulmonary TB 
patients who receive family-based DOTS support program and 
those who receive routine care program. 
 
Research Questions  
  The research questions of this study are stated as follow: 
1. Is the mean score of adherence to health behaviors among patients 
with pulmonary TB after receiving family-based DOTS support 
program higher than the score measured before the intervention? 
2. Is the mean score of adherence to health behaviors among patients 
with pulmonary TB who receive family-based DOTS support 
program higher than the score of those who receive routine care? 
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Theoretical Framework  
  This study aimed to test the effect of family-based DOTS support 
program on adherence to health behaviors among patients with TB. The theoretical 
framework of this study was derived from the conceptualization of the theory of self-
care by Orem. Orem (1995) described the self-care framework to be consisting of the 
theory of self-care, the theory of self care deficit, and the theory of nursing system.  
  First, the theory of self-care was used to assess the self-care requisites 
and evaluate the therapeutic self-care demands. The demands of TB patients compose 
of adhering to treatment, recovering health status, and preventing transmission. 
Treatment success is a desired outcome of TB treatment (through DOTS program). 
Differing from treatment success, adherence to health behaviors measures medication-
taking behaviors and other health related behaviors including taking healthy diet 
and/or executing lifestyle changes (WHO, 2003). Administering self care during TB 
treatment is essential and adhering to the routine is required to achieve success. Mc. 
Donnel, Turner, and Weaver (2001) stated that adherence was one aspect of self-care 
behaviors. 
  Self-care is a practice in which individuals initiate and perform on their 
own behalf in maintaining life, health and, well-being (Orem, 1995, p. 104). Self-care 
consists of universal, developmental, and health care (health deviation) needs (Orem, 
2001). Adherence represents one of Orem’s health deviation self-care requisites for 
prescribed therapeutic activities (Ailinger, Moore, Nguyen, & Lasus, 2006). The 
calculation of adherence to health-related activities was done by comparing actual 
behaviors and determined standard (Konradi & Lyon, 2000). In addition, adherence 
was also defined as client’s self-care based on deliberate action (Ailinger & Dear, 
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1998). Deliberate action means an activity that is driven by purposeful goal or result 
and has two related phases: 1) estimative and transitional operations; and 2) 
production and evaluation operations (Orem, 1995, 2001). 
  Second, the theory of self-care deficit was used to identify the self-care 
agency (SCA). Since the TB patients are required to take medication for a long period 
of time and follow the health behaviors to recover well, the family as dependent care 
agency (DCA) also serves as an extension to the healthcare providers of the self-care 
agency. Orem categorized family into three types of situation, namely, family as basic 
conditioning factors, family as structure for dependent care unit, and family as unit of 
service (Taylor & Renpenning, 1995). Taylor (2001) stated that a family has specific 
purposes to create, maintain, and promote the social, mental, physical, and emotional 
development of each and all of its members. Taylor thus defined family as a system or 
a unit of person-in-relations, with strong social bonds, with commitment and 
attachment. In this study, family is viewed as a structural dependent care unit, which 
provides the kind of care needed by TB patients. Therefore, the participating families 
were prepared to meet the TB patient’s demand by increasing the family’s abilities 
and resources. In order to meet the therapeutic self-care demands, there are many 
systems to be developed through role allocation and interaction as well as some 
combination of independent and interdependent actions (Taylor, 2001).  
  The structure of the self-care agency concept was formalized into three 
structures – a set of power components enabling performance of self-care operations, 
five sets of foundational capabilities and dispositions, and the self-care operational 
capabilities, (Orem, 2001). Foundational capabilities and disposition are utilized as 
baseline and context. Orem (1995, 2001) described three self-care operations that will 
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be enhanced, namely, investigative-estimative, judgment and decision-making, and 
productive operations of self-care agency. Estimative operation helped the clients to 
gain understanding on TB overview, TB & medications/ diet/ exercise and 
management of symptoms and side effects of medications. Transitive operation 
assisted the clients’ decision on care activities by providing choices and discussion 
about their benefits and limitations. The productive operation encouraged the clients 
to make action plans for the patients.  
  Third, the theory of nursing system was applied to identify type of 
nursing system. Orem (2001) established three nursing systems, namely, wholly 
compensatory, partly compensatory, and supportive-educative. The nursing system 
for TB patients is supportive-educative system since the patients are generally 
independent and need support during medication phase. In order to provide 
supportive-educative program, four helping methods of Orem (2001) were used – 
teaching, guiding and directing, supporting, and providing environment. Five factors 
influencing an adherence to health behaviors had been identified and classified into 
patient-related factors, therapy-related factors, socio-economic factors, disease-related 
factors, and health system factors. These factors were used to established contents in 
family-based DOTS support program, which provided four helping methods. 
  The four helping methods were teaching, guiding and directing, 
providing healthy environment, and physiological and psychological support. 
Teaching techniques covered TB overview and health-related behaviors. Guiding and 
directing methods, performed by the families identify barriers and ways to overcome 
them. Providing healthy environment meant to provide environmental conditions that 
motivate the patients and to establish appropriate goals and adjust behavior to achieve 
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results. Physiological and psychological supports were provided to assist the patients 
while going through an unpleasant or painful condition so they can control and direct 
their actions in such situation. These helping methods were employed to develop three 
aspects of self-care operations.  
  This study focused on minimizing the self-care deficits of TB patients 
by improving self-care agency, meeting their therapeutic self-care demands, and 
establishing therapeutic self-care systems. Improving self-care agency was employed 
by maximizing function of the family as a dependent care agent in DOTS support 
program. Self-care demands of TB patients referred to treatment, recovery, and 
preventing transmission by adherence to health behaviors. For TB patients, health 
behaviors mean complying with the anti-TB medication regimen, following healthy 
diet, maintaining environmental hygiene, performing physical activity, preventing 
disease transmission, and avoiding risk factors. Establishing therapeutic self-care 
system is to provide the supportive-educative program to TB patients through 
dependent care agency, using the family as DOT supporter. Lastly, the telephone 
follow-ups were conducted one and two weeks after the intervention to provide 
support to the family to overcome post-intervention obstacles during family-based 
DOTS support program. Additionally, face-to-face follow-ups were performed at the 
fourth and fifth weeks after intervention.  
Figure 1 shows the SCDNT theory which guided the construction of 
the family-based DOTS support program aiming to increase adherence to health 
behaviors among patients with pulmonary TB in this study. 
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Hypotheses 
  The hypotheses of this study are: 
1. The total mean score of adherence to health behaviors among 
patients with pulmonary TB, after receiving family-based DOTS 
support program, is higher than the score measured before the 
intervention. 
2. The total mean score of adherence to health behaviors among 
patients with pulmonary TB, who receive family-based DOTS 
support program, is higher than the score of those who receive the 
routine care. 
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Family-Based DOTS Support Program 
The first week of intervention  
1. Estimative operation using teaching technique 
1.1. TB overview 
1.2. TB & medications 
1.3. TB & diet 
1.4. TB & exercise  
1.5. TB & environmental 
1.6. T & transmission 
1.7. TB & risk factors 
2. Transitive operation using teaching, guiding, 
supporting, and providing environment 
2.1. Decision on care activities  
2.2. Providing choices  
2.3. Discussing the benefits and limitations 
3. Productive operation using teaching, guiding, 
supporting, and providing environment 
3.1. Creating the action plan 
3.2. Evaluation of implementation 
The second week to the fifth week of intervention  
4. Telephone follow-ups (week 2 & 3)   
4.1. Evaluation of implementation and revise or 
continue action plans 
5. Face–to-face follow-ups (week 4 & 5) 
5.1. Evaluation of implementation and revise or 
continue action plans 
 
Figure 1. Theoretical framework of the effect of family-based DOTS support program 
on adherence to health behaviors in patients with pulmonary TB 
Adherence to health behaviors: 
1. Complying with anti TB 
medications 
2. Following healthy diets 
3. Performing physical 
exercise 
4. Maintaining 
environmental hygiene 
5. Preventing disease  
transmission  
6. Avoiding the risk factors 
of TB 
14 
 
Definition of Terms 
  Family-based DOTS support program refers to the fifth-week program 
developed by the researcher based on Orem’s SCDNT theory (1995, 2001). The 
program aims to assist TB patients increase their adherence to health behaviors. This 
program also involves family as a dependent care agent whose role is to provide 
support to the patients. Four major methods are used throughout the implementation 
of the program: teaching, guiding, supporting, and providing environment to develop 
system of care. The program includes three structures of care operations, namely, 
estimative operation, transitive operation, and productive operation. Moreover, this 
program includes two follow-up telephone calls at the second and third week, 
following the treatment, with the TB patient and his/ her family. Additionally, face to 
face follow-ups are conducted at the last two weeks of intervention. 
  Routine care program refers to the regular care services provided by 
the TB patient’s health care provider at the community health center facility. The 
services include regular check-ups, taking medications every week in the intensive 
phase and every two weeks in the continuation phase, laboratory examination, and 
educational program. The educational program is individualized, using traditional 
approach in the beginning of TB treatment for every TB patient, and the topics are 
generally related to TB disease and its treatment. 
  Adherence to health behaviors refers to measurement of frequency of 
time in a week when the TB patients following through certain activities – complying 
with anti-TB medication, following healthy diets, performing physical exercise, 
maintaining environmental hygiene, preventing disease transmission, and avoiding the 
risk factors of TB. These behaviors are measured two times in the first week and 
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again during the fifth week of the intervention by the using modified Tuberculosis 
health behaviors questionnaire, which was originally developed by Biswas (2010). 
Higher scores indicate the better adherence to health behaviors.  
 
Significance of the Study 
The outcomes of this study will provide evidence regarding the 
utilization of family-based DOTS support program in improving adherence to health 
behaviors among patients with pulmonary TB. The evidence will prove that DOTS 
can achieve success outcomes, particularly cure rate and treatment completion rate. In 
addition, the results of this study will provide valuable information for future studies 
regarding adherence to health behaviors and family-based DOTS support program in 
Indonesia. 
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CHAPTER 2 
LITERATURE REVIEW 
 
In order to understand key concepts of this study, relevant literatures 
are explored and reviewed. The outlines of this review are presented as follow: 
1. Situation of Tuberculosis control 
1.1 Incidence and prevalence of Tuberculosis 
1.2 Tuberculosis treatment and control update 
1.3 DOTS programs  
1.4 Evaluation outcomes of Tuberculosis control 
2. Adherence to health behaviors 
2.1 Concept of adherence  
2.2 Components of health related behaviors of TB 
2.3 Factors influencing adherence to health behaviors 
2.4 Measurements of adherence to health behaviors 
3. Family-based DOTS support program for patients with TB 
3.1 Concept of family support 
3.2 Family as dependent care agent 
3.3 Evidence-based practices of FM DOT supporter for TB patients 
3.4 Family-based DOTS support program for TB patients in increasing adherence 
to health behaviors 
4. Summary  
17 
 
Situation of Tuberculosis Control 
  The situation of TB control can be described by incidence and 
prevalence of TB, updates on TB treatments and control, DOTS programs, outcome 
evaluation of TB control, and factors influencing adherence behaviors. 
 
  Incidence and prevalence of Tuberculosis 
  Tuberculosis worldwide. TB persists as a major public health problem 
worldwide for it has caused high rates of morbidity and mortality caused (WHO, 
2008). The global incidence rate of TB was estimated at 140 per 100,000 people and 
the prevalence rate was 164 per 100,000 people in 2009 (WHO, 2010a). Nonetheless, 
the mortality rate was estimated at 19 per 100,000 people in the same year. This 
infectious, airborne disease has contributed around nine million new cases of 
infections and close to two million of deaths each year (WHO, 2010c). TB has 
affected every country around the world but 85% of the cases occur in Africa (30%) 
and Asia (55%). Furthermore, a challenge posed on TB control by HIV and MDR-TB, 
which make up over 10% and 0.5% of TB cases respectively each year. 
TB is one of many diseases that are covered by the sixth goal of 
Millennium Development Goals (MDGs). Recently, MDGs has reported to achieve 
90% treatment success rate in 7 million new cases (WHO, 2010a). One of MDGs’ 
missions that specifically targets TB control is to halt and begin to reverse the 
incidence of TB, among other major diseases, by 2015. Reduction of incidence, 
prevalence, and death rates among the TB-infected as well as proportion of TB cases 
detected and cured under DOTS are indicators of MDGs’ accomplishment (WHO, 
2010c).  
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WHO (2010a) reported that though the prevalence rate has been falling 
in six regions of the world but the MDGs’ 2015 target is out of reach. However, this 
target could be achieved in three regions, namely, the Americas, the Eastern 
Mediterranean, and the Western Pacific. In addition, incidence rates were also 
reported to have decreased in five regions –Africa, the Americas, Europe, the Eastern 
Mediterranean, and the Western Pacific – while the incidence rates in South-East Asia 
has been stable. Between 1990 and 2009, mortality rate has dropped significantly for 
about 35%, therefore, the ambitious target of 50% decrease by 2015 could materialize 
if the current rate continues to decline. 
Nevertheless, this ambitious mission will surely face some challenges 
along the way particularly drug resistance and co-morbidity with HIV/ AIDS. An 
interrupted, erratic or inadequate TB therapy would easily cause drug resistance. 
WHO (2010b) reported that 440,000 people had MDR TB worldwide and a third of 
them died. Of those MDR cases, 50% cases occur in China and India. Obviously, it is 
estimated that 490,000 new MDR will occur each year. In addition, the incidence of 
MDR-TB is at higher risk because TB patients are co-infected with HIV. 
Tuberculosis in Indonesia. In 2009, Indonesia ranked fifth for having 
the highest TB burden in the world, after India, China, South Africa, and Nigeria 
(WHO, 2010a). This rank has been down compared to the previous year when the 
country ranked third place. Furthermore, prevalence and incidence rates of TB in 
Indonesia were estimated 285 and 189 per 100,000 people respectively in 2009 
(WHO, 2010a). Mortality rate of TB, excluding HIV, in Indonesia was 27 per 100,000 
people in 2009. Incidence rate of TB in Indonesia is assumed to be steady and so the 
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country has a good chance to achieve the target of halving the 1990 mortality rate by 
2015. 
In West Java, one of the provinces in Indonesia, had an estimate of 
44,407 new cases of TB in 2009 (Indonesia Ministry of Health, 2009) which was 
reported to be the highest number of TB cases in all of Indonesia. Composite 
development, economy, population, behavioral and biological risk factors, health 
services, and TB control programs are the determinants of the high level of incidence 
TB (Dye, Lönnroth, Jaramillo, Williams, & Raviglione, 2009). These determinants 
occur in West Java, particularly the high number of population, the significant number 
of HIV/ AIDS cases, and the significant number of smokers, and the environmental 
problems. Case detection rate of TB in this province in the year 2009 was 70.4%. This 
disease usually occurs among the productive age group, ranging from 15 to 64 years. 
There were 85.1% of patients who were treated in 2008 and the achieved success rate 
of treatment was 91% (Indonesia Ministry of Health, 2009).  
Like dealing with TB at a global level, Indonesia also faces challenges 
to control TB. Both drug-resistant and co-morbidity with HIV/ AIDS should be 
overcome properly. Cases of MDR-TB are reported to be 2.2% among all TB cases 
nationally while HIV cases are estimated at 3% among all TB cases (WHO, 2009a). 
Even though the MDR rate in Indonesia is 4% lower on average than the estimated 
rate in South Asian region, the anticipated actions should continue. 
 
  Tuberculosis treatment and control update 
  TB is an infectious disease caused by Mycobacterium Tuberculosis. 
The disease spreads when droplet nuclei of Mycobacterium tuberculosis, that is 
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suspended in the air, are inhaled. Initial infection has minimal clinical manifestation 
so most patients are asymptomatic. However, cough and dyspnea commonly occur 
while symptoms are present (Schlossberg, 2010). Furthermore, chest pain, sore throat, 
weight loss, night sweat, and systemic complaints of fever and malaise also 
occasionally take place (Jacob, Mehta, & Leonard, 2009; Schlossberg, 2010).   
  Daley et al presented that higher risk of TB is related with age (climax 
between 15 and 29 years), HIV, increasing tuberculin skin test size, and inversely 
from time of exposure (Jacob, Mehta, & Leonard, 2009). Reactivation happens in at 
least two thirds of adult TB cases and it is more likely acute in symptom 
presentations. HIV infection, insulin-dependent diabetes, transplant, or chronic renal 
failure are risk factors of reactivation and might be affected by older age, ethnicity, 
and duration of latent infection (Horsburgh, 2004). 
  TB commonly affects human lungs. Nevertheless, Mycobacterium 
Tuberculosis could spread from the lungs to other organs such as pleura, lymph 
nodes, abdomen, genitourinary tract, skin, joints and bones, and meninges (WHO, 
2009b).  Since this contagious disease is treatable, treatment has important roles for 
TB patients for curing, restoring quality of life and productivity, preventing death 
from active TB or its late effects, preventing relapse of TB, reducing transmission of 
TB to others, and preventing the development and transmission of drug resistance 
(WHO, 2009b).  
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The essential first-line of anti-Tuberculosis drugs. There are five 
essential TB drugs recommended by WHO: Isoniazid (H), Rifampicin (R), 
Pyrazinamid (Z), Streptomycin (S), and Ethambutol (E). All drugs should be stored in 
well-closed containers and away from light to prevent damage of drugs. 
Isoniazid consists of hydrazide of isonicotinic acid and it is an 
effective bactericidal against replicating tubercle bacilli (WHO, 2009b). Dosage of 
this medication is 5 mg/Kg daily and 10 mg/Kg three times weekly. The maximum 
dosage is 300 mg daily and 900 mg three times weekly (WHO, 2009b). Possible 
adverse effect of this regimen is systemic or cutaneous hypersensitivity reactions 
particularly during the first week of treatment (WHO, 2009b). However, hepatitis is 
the most important adverse effect and the risk will increase because of age and 
underlying liver disease (Mandell, Bennet, & Dollin, 2009). 
Rifampicin as a complex macrocyclic antibiotic has role in inhibiting 
ribonucleic acid synthesis in a broad range of microbial pathogens (WHO, 2009b). 
Dose of rifampicin for adults is 10 mg/kg and 600 mg maximum dose daily. Effect of 
a potent sterilizing can act against tubercle bacilli in both cellular and extracellular 
locations. Orange discoloration of the urine, tears and other body fluids are common 
side effects (Sahbazian & Weis, 2005). In addition, pruritus and gastrointestinal 
distress rarely occur but influenza-like syndrome is a more serious adverse effect of 
Rifampicin. 
Pyrazinamide is used as primary drug in the initial and intensive phase 
of active TB therapy (Sahbazian & Weis, 2005) and it is also highly helpful with 
acute inflammatory (WHO, 2009b). Shortening the usage of this drug has been 
enabled so to reduce the risk of relapses. The dose for adults is 25 mg/ kg for daily 
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administration and 35 mg/kg for trice weekly administration (WHO, 2009b). The 
drug may cause gastrointestinal intolerance as side effect. 
Streptomycin is sensitive gram negative infection and effective for TB 
treatment. This is administered via deep intramuscular injection and therefore could 
incur rash, induration or sterile abscess around injection sites (WHO, 2009b). In 
addition, cutaneous hypersensitivity reactions can arise. The given dose is 15 mg/kg 
daily or intermittently and maximum dose daily is 1000 mg.  
Ethambutol has been proven effective for pulmonary TB treatment. It 
is to be combined with both Isoniazid and Rifampicin during the initial treatment to 
prevent or delay the emergence of resistant strains (Doster, Murray, & Newman, as 
cited in Sahbazian & Weis, 2005; WHO, 2009b). Daily dose is 15mg/kg and 30 
mg/kg for three times weekly.  
Treatment regimens. The standard treatment for TB has two phases: 
the intensive phase and the continuation phase. Treatment can be given daily and 
intermittently. However, optimal result will be achieved from daily drug 
administration rather than three days a week. The intermittent drug administration, or 
three times a week regimen, is only acceptable for patients receiving DOTS who do 
not live with other HIV patients or stay in locations where HIV is prevalent (WHO, 
2009b).  
Every patient should take standardized regimen, which means all 
patients in a defined group receive the same treatment regimen (WHO, 2009b). In 
order to assign standard regimen, patients are grouped by their insurance registration, 
new patients and previously treated patients. New patients are those who have never 
received a treatment for TB or have taken anti-TB drugs for less than 1 month. 
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Conversely, previously treated patients refer to those who have received 1 month or 
more of anti-TB drugs in the past. Table 1 presents registration group of TB (WHO, 
2009b, p. 27). 
 
Table 1 
WHO’s Registration Group of TB  
Registration group Bacteriology 
Outcome of latest 
treatment 
New + or - - 
Previously treated: 1. Relapse + Cured 
Treatment completed 
2. Failure + Treatment failed 
3. Default + Defaulted  
Transfer in: A patient who has been 
transferred from another TB register to 
continue treatment 
+ or - Still on treatment  
Other  + or - All cases that do not 
fit the above 
definitions. 
 
  WHO (2009b, p. 37 & 43) has updated the standard regimen for both 
new and previously treated TB patients.  Table 2 presents categories recommended 
treatment. 
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Table 2 
WHO’s Standard Regimens for TB Patients 
Registered Group Intensive Phase Continuation Phase Comments 
New patients 2 Months of HRZE 4 Months of HR For TB Meningitis, 
Ethambutol should be 
replaced to 
Streptomycin 
 2 months of HRZE 4 months of HRE Applied in countries 
with a high level of 
resistance of Isoniazid 
and Isoniazid drug 
susceptibility testing is 
not done 
Previously treated 
patients: failure, 
relapse, and default 
2 months HRZES/ 
1 month HRZE 
5 months HRE Regimen should be 
modified once DST 
available 
  
  The adverse effects inhibit patients from taking medications. 
Therefore, it is important for health care providers or supporters to recognize the 
adverse effects of each TB medication and how to handle them. There are two types 
of side effects which are major and minor side-effects. Patient should inform that 
every side effect requires an intervention from healthcare providers and to stop taking 
medication if exhibiting serious side effects. However, patients may continue taking 
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medication for minor side effects although drug doses should be reassessed. Table 3 
presents the adverse effects of TB medications and the dealing actions appropriate 
interventions (WHO, 2009b, p. 61). 
 
Table 3  
Side Effects of TB Medications 
Side-effects Probable Causes Management 
Major   
Skin rash with or without itching Streptomycin, Isoniazid, 
Rifampicin, Pyrazinamid 
Stop TB medications 
Deafness (no wax on otoscopy Streptomycin Stop Streptomycin 
Dizziness (vertigo and nystagmus) Streptomycin Stop Streptomycin 
Jaundice (other causes excluded), 
Hepatitis 
Isoniazid, Pyrazinamide, 
Rifampicin 
Stop TB medications 
Confusion (suspect drug-induced 
acute liver failure if there is 
jaundice) 
Most of anti-TB drugs Stop TB medications 
Visual impairment (other causes 
excluded) 
Ethambutol Stop Ethambutol 
Shock, purpura, acute renal failure Rifampicin Stop Rifampicin 
Decrease urine output Streptomycin Stop Streptomycin 
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Table 3 (continued) 
Side-effects Probable Causes Management 
Minor   
Anorexia, nausea, and abdominal 
pain 
Pyrazinamide, 
Rifampicin, Isoniazid 
Take drugs with small meals 
or before bedtime and advise 
patients to swallow pills 
slowly with small sips of 
water 
Joint pain Pyrazinamide Aspirin or non-Steroidal 
anti-inflammatory or 
Paracetamol 
Burning, numbness, or tingling 
sensation in the hands or feet  
Isoniazid Pyridoxine 50-75 mg daily 
Drowsiness Isoniazid Reassurance and give drug 
before bedtime 
Orange/ red urine Rifampicin Reassurance. Patient should 
be informed when starting 
treatment that the symptom 
may occur and is normal. 
Flu symptoms (fever, chills, 
malaise, headache, bone pain) 
Intermittent dosage 
Rifampicin 
Change from intermittent to 
daily Rifampicin 
administration 
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  In conclusion, TB treatment consists of intensive and continuation 
phases over six months period. Isionazid, Rifampicin, Pyrazinamid, Streptomycin, 
and Ethambutol are main medications for TB. These medications can be taken daily 
or intermittently. Like other medications, these medications also have side effects that 
require management.  
 
  DOTS program 
  Since TB still continues as major global health concern particularly in 
developing countries, WHO has designed the TB stop partnership strategy to reduce 
global burden TB and this program is in line with the millennium development goals 
including: 1) pursueing high-quality DOTS expansion and enhancement; 2) 
addressing TB/ HIV, MDR-TB and the needs of poor and vulnerable populations; 3) 
contributing to health system strengthening based on primary health care; 4) engage 
all care providers; 5) empowering people with TB, and communities through 
partnership; and 6) enabling and promoting research (WHO, 2010a; WHO, 2010b). 
There are two pillars to control effectively through early case detection and treatment 
(Maciel, Silva et al., 2008). These pillars are similar with MDGs that has two 
measurements related to TB specifically DOTS implementation and TB impacts (Dye, 
Watt, Bleed, Hosseini, & Raviglione, 2005). Both case detection and treatment 
success are used to measure implementation of DOTS whereas incidence, prevalence, 
and death rates are indicators for impact of TB control. 
  DOTS is the most effective strategy available to control TB (WHO, 
1999). DOTS has been introduced since 1995 and has been effective and successful in  
decreasing TB (WHO, 2010a). DOTS program has been successfully applied in many 
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developed and developing countries. The number of TB patients who were 
successfully treated in DOTS program is 41 million between 1995 and 2009. In 
addition, more than 6 million people, including children and women, have been saved. 
Therefore, DOTS is claimed to be a program that has been proven to control TB. 
DOTS is thus recommended for TB control, requiring its essential five elements: 
sustainable government commitment, quality assurance of sputum microscopy, 
standardized short-course treatment (including direct observation of therapy), regular 
supply drugs, and establishment of reporting and recording systems (WHO, 2010a). 
DOTS activity could be done in various setting such as chest clinics, general health 
centers, hospitals, patient’s work place, patient’s resident, and schools. 
  Sanchez and Bertolozzi (2009) listed DOTS strength: 1) there is a 
dialogue and sharing of information between health professionals and patients which 
creates bonding; 2) it can identify patients’ needs; 3) it reduces possibility of relapses; 
4) it facilitates correct method of medication; and 5) it reduces resistance to 
medication; 6) it helps health professionals to provide educational information. In 
addition, one of the most important aspects of DOTS strategies is that it is applicable 
in a diverse social, economic and political context (Frieden & Driver, 2003). At the 
same time, limitations of DOTS were also specified: 1) limited number of health care 
providers and lack of collaboration with professionals of other disciplines; 2) limited 
resources to meet patients’ needs; 3) resistance from some health professionals to 
provide care to patients; 4) deficiencies in the referral network and the system of 
health information. 
  The limitations of DOTS should not however stop the continuation of 
the program considering its mounting benefits. Directly Observed Treatment (DOT) 
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as part of the wider DOTS is important at least during the intensive phase of treatment 
to make sure that the drugs are taken in the right combinations and for the appropriate 
duration (WHO, 1999). DOT is a trained and supervised person who observes the 
patient swallowing the medication (WHO, 2002). A family-based DOTS support 
program provides knowledge and understanding to DOT supporters, not only about 
the medication but also all health behaviors. A patient who has a DOT supporter is 
believed to achieve better results than one who is self-supervised. Kamolratanakul, et 
al (1999) assessed effectiveness of DOT and self-administered (SA) on treatment 
outcomes and found that both cure and completion rates were significantly higher in 
the DOT cohort than in the SA. Furthermore, they analyzed that district and 
provincial hospitals confirmed the benefits of DOTS more than referral centers.  
Health care providers are well aware of problems with their clients 
adhering to a drug regimen because they have the responsibility to ensure that 
treatments are carried out (Pascucci, Leasure, Belknap, & Kodumthata, 2010). 
However, Mesfin, Mishra, Hansen, Sabroe, Kafle (2006) found that those health 
professionals who have poor-grade communication were significantly associated with 
non-adherence. Newell et al (2006) also stated that patients, whose treatment 
supervisors were not properly trained and were incapable of managing illnesses 
occurring during treatments, were more likely to interrupt their treatments. The choice 
of treatment supporter should be based on access, patient’s preference and availability 
of HCV resource (Wright, et al., 2004) 
  Furthermore, in order to deal with the limitations of DOTS, 
maximizing the role of DOTS supporters besides the healthcare providers might be 
helpful. DOT supporters can be healthcare provider, family members and community 
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members. However, there are no robust confirmations in identifying the best DOT 
supporter for TB patients because of varying results in each attempting study. Since 
family is the closest and most basic source of support for patients, the health care 
providers can facilitate a patient’s family to take part throughout the participation in 
DOTS. Maciel, Silva, et al (2008) found that DOT which was supervised by family 
members has proven to help patients to more likely be adherent to treatments. 
  Million patients have received treatments under the DOTS approach 
(WHO, 2005). Sanchez and Bertolozzi (2009) argued that DOTS has a role in 
treatment adherence and promotes interfaces and conversations between care 
providers and patients, which help identify health needs and appropriate interventions. 
Nonetheless, implementation of DOTS faces some challenges: health sector reforms, 
the worsening HIV epidemic, and the emergence of drug resistance of TB. Adherence 
to treatment is essential to achieve treatment goals. Utilization of DOTS will help 
improving adherence to treatment (Branley, 2009). 
Overall, DOTS implementation needs to be improved by escalation the 
strength and overcoming the limitations. DOTS supervision would help TB patients to 
achieve succesful treatments by having adherence behaviors. Healthcare providers, 
family members and community health workers are possibly DOTS supervision. The 
implementation of DOTS program only focused on medication instead of the wholly 
of health behaviors. Family members as DOT supporters in the DOTS program had 
not been prepared well and they were only assigned without clear explanation of the 
roles as DOT supporter. A family-based DOTS support program that emphasize the 
role of family as dependent care agent and concerns all health behaviors of TB will 
increase effectiveness of DOTS. Therefore, family participation in every aspect of 
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care for TB patients by providing knowledge, taking part in decision making and 
action plan needed to be enhanced. As a result, family as DOT supervision will help a 
TB patient to gain greater adherence behaviors and successful treatment. 
 
  Evaluation outcomes  of Tuberculosis control 
  Evaluation outcomes of TB control refer to case detection rate and 
successful TB treatment. In addition, the outcomes can also be divided into treatment 
outcome and behaviors outcome. According to WHO (2009b), the case detection rate 
is calculated by number of new smear positive cases notified divided by number of 
new smear positive case estimated for that year. WHO (2009b) defined treatment 
outcomes into some criteria including cure, completed treatment, treatment failure, 
died, default, and transferred out. Successful treatment is the main goal of TB control 
and is dependent on some factors, such as susceptibility of the bacterial strain to anti-
TB drugs, the regimen employed and its duration, the availability of drugs and the 
adherence of both treatment provider and patient (WHO, 2009b). The definition of 
each treatment outcome will be explained in the following paragraph.  
  Cure means a patient whose sputum smear or culture is positive at the 
beginning of the treatment but then found to be negative in the last month of treatment 
and on at least one previous occasion. Completed treatment means if a patient who 
has completed treatment and does not have negative sputum smear or culture result in 
the last month of treatment and on at least one previous occasion. Treatment failure 
means a patient whose sputum smear or culture is positive at the 5th months or later 
of treatment and if a patient is found to harbor a multidrug-resistant strain of TB any 
time during therapy. Died refers to a patient who dies for any reasons during 
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treatment. Default means patient whose treatment was interrupted for two consecutive 
months or more. Transferred out refers to a patient who has been transferred to 
another recording and reporting unit though his treatment outcome is unknown. 
Finally, successful treatment means a sum of cured and completed treatments.  
  These treatment outcomes are used by healthcare providers to report 
TB management. Successful treatment requires adherence behaviors to a minimum of 
6 months of treatment with multiple drugs (Jasmer, Seaman, Gonzalez, Kawamura, & 
Osmond, 2004). Medication adherence is only one of the adherence or health 
behaviors, all of which should be obeyed by patients. A long duration of TB is not 
only a barrier to global TB control (Bayer & Wilkinson, as cited in 
Anuwatnonthakate, Limsomboon, Nateniyom, Wattanaamornkiat, & Komsakorn, 
2008) but possibly also produces low adherence to treatment. Maartens & Wilkinson 
(2007) stated that this condition reduces the cure probability, inclines the risk of 
relapse after treatment and possibility of drug resistance (Anuwatnonthakate et al., 
2008). Therefore, to achieve good treatment outcomes, adherence health behaviors 
should be increased during TB treatment. 
 
Adherence to Health Behaviors 
  Adherence to health behaviors is an important issue related to chronic 
disease, specifically TB, since patient has to take medication for 6 months. The 
concept, influencing factors and measurement of adherence behavior will be 
explicated in the following paragraph. 
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  Concept of adherence 
  Adherence is often used interchangeably with compliance and 
concordance. WHO (2003) has however stressed a need to differentiate adherence 
from compliance. Obviously, concordance is a manifestation of adherence. A 
concordance model will change how patients feel about adhering after healthcare 
providers shifting their perceptions and attitudes (Rose et al., Bissell et al., as cited in 
Bissonnette, 2008). However, a concept analysis study has defined and concluded that 
there is no specific differentiation between the concepts of adherence and compliance 
that have been used in most research (Bissonnette, 2008).  
  In the 1970s, compliance research was dominated by physicians and 
behavioral scientists and then Marston promoted a concept that nursing should tone its 
experience and understanding of patient compliance (Sackett & Haynes, as cited in 
Bissionnate, 2008). Therefore, since 1973 non-compliance is categorized as a nursing 
diagnosis based on North American Nursing Diagnosis Association (NANDA). 
NANDA stated that there are certain implications of non-compliance that focus on 
shared decision-making and agreement between patient-healthcare professional 
(NANDA-International, as cited in Lehane & McCarthy, 2009). 
  Compliance is as “an active responsible act of care in which the 
individual works to maintain health in close collaboration with the health care 
personnel” (Murphy & Canales, as cited in Cohen, 2009). Moreover, Lutfet & Wisher 
declared that compliance is without consideration to the patients’ independence, 
autonomy and ability to take an active role in their health care and patients just obey 
and conform to the provider’s instruction (Robinson, Callister, Berry & Dearing, 
2008).    
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  Consequently, WHO introduced the term adherence to replace 
compliance because compliance implies blame on the patients while adherence 
includes patients’ agreement to the prescribed recommendations rather that passively 
following ones (WHO, 2003). This approach is similar to one by Bissionnate (2008), 
who has identified that the most common attributes identified in the adherence 
literature include decisional conflict, predictability, personal experience, power, 
agreement and pervasiveness. WHO (2003) defined adherence as the extent to which 
the patient follows medical instructions. Most researches concern adherence to 
medication but adherence actually also covers health-related behaviors beyond 
prescribed medications. Haynes and Rand defined adherence of long-therapy as “the 
extent to which a person’s behavior–taking medication, following a diet, and/or 
executing lifestyle changes, corresponds with agreed recommendations from a health 
care provider” (WHO, 2003, p.4). Benner et al (2002); Carpenter (2005); Chatterjee 
(2006); Treharne et al., as cited in Cohen (2009), defined adherence as determination 
in the practice and continuation of desired health behaviors and this is the result of 
active participation and agreement.  
  Furthermore, Machtinger and Bangsberg (2005) mentioned that both 
terms adherence and non-adherence are defined to be nonjudgmental and accounts of 
fact rather than expressions of blame to the patient or health care provider. Hearnshaw 
and Lindenmeyer, as cited in Lehane and McCarthy (2009), categorized adherence 
into five types: 1) coincidence of patient behavior with professional advice; 2) 
relationship as part of the process of care; 3) outcome and process targets; 4) taking 
medication as prescribed; and 5) other factors influencing behavior category. This 
definition includes the bio-psycho-social approach that adherence is built in patients’ 
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motivation, health beliefs and habits. Equally, Rose, et al., as cited in Bissionnate 
(2008), defined adherence as a collaborative effort between healthcare providers and 
consumers to achieve mutually derived health goals. It is completed by Sabate´, as 
cited in Bissionnate (2008), that included patient related and healthcare system related 
as consequences of adherence in addition to healthcare-professional related. 
Recognizing the patient’s right to choose whether to follow treatment 
recommendation is important aspect of adherence (Robinson, Callister, Berry & 
Dearing, 2008). Therefore, adherence is seen as being more patient-centered than 
compliance because adherence concerns more on patient involvement and the patient-
health care provider’s relationship.  
  Concordance is the next step of adherence (Cohen, 2009). It was 
initially defined as an agreement reached after a negotiation between a patient and a 
health-care professional which respects the beliefs and wishes of the patient in 
determining whether and how medicines are taken (Royal Pharmaceutical Society of 
Great Britain [RPSGB], as cited in Lehane & McCarthy, 2009). National Prescribing 
Centre developed and defined concordance as a process of prescribing and 
medication-taking based on partnership based on basic principles such as patients 
have enough knowledge to participate as partners, health professionals are prepared 
for partnership, prescribing consultations involve patients as partners and patients are 
supported in taking medicines (Lehane & McCarthy, 2009). As a result, it is not 
known as the actual of medication-taking behavior but it predominantly concerns the 
dynamic of the healthcare professional and patient’s interaction (Bell, Airaksinen, 
Lyles, Chen, & Aslani; Cribb, Barber, as cited in Lehane & McCarthy, 2009). On the 
other hand, Treharne et al (2006) stated that there is a process of enlightened 
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communication between the patient and the healthcare professional leading to an 
agreed treatment and ongoing assessment to achieve optimal course (Snowden, 2008). 
Hobden (2006) mentioned that the concordance aims to support patients involvement 
in their health care sequentially to increase patient satisfaction with their service. 
Therefore, patients’ perspective is focused by the true concordance.  
  Cohen (2009) stated that rates of non-adherence are approximation 
between 50% - 80% for chronic disease management, medication, and lifestyle 
changes. DiMatteo as cited in Cohen (2009), stated that patients’ adherence are 
judged while they do what the healthcare provider recommends. Unlike compliance, 
which is believed to imply a passive relationship, adherence involves active 
participation in the treatment regimen, collaboration, persistence in practice, and 
maintenance of behavior (Benner et al., 2002; Carpenter, 2005; Chatterjee, 2006; 
Treharne et al., as cited in Cohen, 2009). Furthermore, Cohen (2009) mentioned that 
concept of adherence should be expanded to cover patient-provider concordance or 
therapeutic alliance to reflect a change in healthcare provision that includes 
consensual prescribing, mutual goal setting, and shared decision making. 
Additionally, credible health education, goal setting, decision support, healthcare 
provider influence, and presence of a collaborative relationship, self-efficacy, and 
social-demographics influencing will affect adherence. Open communication and 
support in decision making would help patients increase adherence to healthy 
behaviors (Barlow, Wright, Sheasby, Turner, & Hainsworth, 2002; Schaffer & Yoon, 
as cited in Cohen, 2009). 
  Nowadays, adherence is preferred in the field of medication-taking 
behavior because this concept integrates certain important dimensions of both 
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compliance and concordance (Aronson, 2007; Lehane & McCarthy, 2009). Active 
participation in the treatment regimen, collaboration, and persistence in practice, and 
maintenance of behavior are entailed by adherence (Benner et al., 2002; Carpenter, 
2005; Chatterjee, 2006; Treharne et al., as cited in Cohen, 2009).  
  Adherence in this study is parallel with SCDNT theory. Adherence is 
viewed as self-care behavior that is associated with and affected by certain 
characteristics of the health problem, the patient, and the health care system (Mc. 
Donnell, Turner, & Weaver, 2001). In addition, adherence also is defined as client’s 
self care based on a deliberate action (Ailinger & Dear, 1998). Orem (1995, 2001) 
stated that self care is the regulation of one’s functioning and the development that is 
necessary to maintain health. Self care consists of universal, developmental, and 
health care (health deviation) needs (Orem, 2001).  Adherence represents Orem’s 
health deviation self-care requisites to perform prescribed therapeutic activities 
(Ailinger, Moore, Nguyen, & Lasus, 2006). 
  To sum up, adherence in this study is defined as part of self-care 
behaviors in performing prescribed therapeutic activities. It includes not only 
medication behaviors but also other health behaviors. In the context of TB, the 
adherence may be divided into process and outcome. Outcome refers to the outcomes 
of TB treatment, such as success rate, cure rate, complete rate, and default. 
 
  Components of health-related behaviors of Tuberculosis 
  Health behavior is broken up into: personal attributes, such as beliefs, 
expectations, motives, values, perceptions, and other cognitive elements; personality 
characteristics, including affective and emotional states and traits; other patterns of 
38 
 
behaviors, actions and habits that are related to health maintenance, health restoration, 
and health improvement (Gochman, 1988). In addition, health behavior includes not 
only observable, over actions, but also the mental events and states of feeling that can 
be reported and measured. Health behaviors for TB are complying with TB 
medications, following healthy diets, performing physical exercise, maintaining 
environmental hygiene, preventing disease transmission, and avoiding risk factors of 
TB (Biswas, 2010). 
  Complying with TB medications. Tb is a treatable infectious disease. 
Since TB patients must take medications for over 6 months, complying with 
medications is essential for TB patients to achieve successful treatment. In addition, 
medication adherence to the long course of TB treatment is complex and with a lot of 
influencing factors on medication-taking behaviors (Munro et al., 2007). Treatment 
adherence refers to adherence to regimens of multiple drugs, taking medications 
regularly, and continuation of medication for a prescribed period. McDonnel, Turner, 
and Weaver (2001) viewed medication adherence as a self-care health behavior that is 
correlated with and influenced by certain characteristics of the health problem, the 
patient, and the health care system. The reasons of patients stopping the medications 
are adverse effects, feeling cured and bored to take medications.  
Following healthy diets. Since TB patients have nutritional problems, 
good nutrition is thus required to maintain and enhance the nutritional status of TB 
patients. The association between malnutrition and TB has in fact been identified. 
Nutritional status is affected by TB at the time of diagnosis as well as during 
treatments. This may occur because of increasing energy expenditure, decreasing 
energy intake, or insufficient use of food. In taking and maintaining healthy nutrition 
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would help speed up recovery, reduce the duration of infection, and provide a chance 
to regain the weight as needed.  
Karyadi et al., as cited in Abala et al (2005), found that there was a 
significant difference of micronutrient status between TB patients and healthy 
controls. Generally, it was found that TB patients had poor micronutrient in 
Indonesia. However, low serum albumin is only found in malnourished TB patients, 
not in well-nourished TB patients.  Kennedy et al (1996) found data that shows that 
patients with TB in Tanzania frequently have malnutrition both before and after TB 
treatment. 
Therefore, TB patients should receive sufficient nutrients. Total 
calories for TB patients is suggested at 4500 Kcal/day, specifically intake of 
carbohydrate, protein, and fat must be approximately 600, 900, and 160 g/day 
respectively (Coker et al., 2005). Healthy and good nutrition would thus help TB 
patients to gain more weight and improve nutritional status. Furthermore, weight gain 
is used to assess the patient’s response to treatment and poor weight gain is 
considered to be a dangerous sign (Kennedy et al., 1996).  
Performing physical exercises. WHO (2010d) has recommended that 
the adults who aged 18-64 years should put in at least 150 minutes of moderate 
activity a week. Physical activity includes recreational activity or physical activity 
during leisure time, transportation (walking or cycling), occupational work, household 
chores, play games or other activity. Like any healthy people, TB patients should 
perform physical exercise. However, the type of physical exercise should be modified 
since TB patients cannot handle activities requiring high exertion. TB patients could 
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perform light exercises such as walking and breathing exercise. More energy used 
would positively influence the recovery of patients.   
Maintaining environmental hygiene. Housing is an essential element to 
provide and control environmental hygiene. Health standards of housing that is 
suitable for TB conditions are sanitation; households need to be kept in a clean and 
sanitary condition. There are three ways of obtaining TB – primary progression of 
infection called primary TB, endogenous reactivation of latent bacilli from a previous 
infection, and exogenous re-infection following resolution of a previous infection. 
The last two are known as post primary TB (McKinney, Jacobs & Bloom, as cited in 
Acevedo-Garcia, 2000). Key factors of TB transmission are therefore the homes and 
the workplaces that are overcrowded and lack ventilation. Howden-Chapman (2004) 
has revealed that crowded housing is associated with higher rates of infectious disease 
transmission. Bailie & Wayte (2006) stated that crowded housing is more likely to 
worsen the range of health effects of environmental smoke.  
Department of Family and Community Services (Bailie & Wayte, 
2006) proposes nine healthy living practices, some of which are recommended for TB 
conditions – removing waste safely, improving nutrition, reducing crowding, and 
reducing dust are appropriate for TB conditions. Free from dust and polluted air 
would help TB patients during treatment. Therefore, it is important that a patient’s 
household is also free of smokers. In addition, crowded home must be avoided.    
Preventing disease transmission. TB is a communicable disease and 
can be transmitted via expelled airborne droplets. Therefore, individuals who 
repeatedly breath air contaminated by an infectious patient may become infected. 
Generally, close contact with the infected will likely lead to infection. According to 
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CDC and ATS (1991), 30 % of those who are in close contact will be infected while 
only 15% of those who have non-close contact get infected (Acevedo-Garcia, 2000). 
The individuals who have history of contact with active TB will have no cellular 
immune response within the first 24 hours of contact, the response will however occur 
after 4-8 weeks (Dunlap & Briles; Peloguin & Berning, as cited in Acevedo-Garcia, 
2000). The exposed individuals will be sick while the cellular immune response 
cannot control the TB organism so progression to active state arises. The probability 
of individuals developing active TB is about 10% -- 50% of these cases occur within 
the first 2 years of infection and the other 50% occur later while the immune systems 
weakens (Murray, Styblo, & Rouilon; Peloguin & Berning, as cited in Acevedo-
Garcia, 2000).  
Therefore, it is essential to prevent disease transmission. TB patients 
possibly transmit the disease to healthcare providers, family members, and others. 
Prevention can take place several ways, such as asking patients to conceal their 
mouth, proper waste of sputum, for example. Furthermore, the number of people in a 
house will increase the risk of disease transmission. 
Avoiding TB  risk factors. Cigarette smoking is known as a major risk 
factor of TB. Beck and Doyle differentiated smokers into two groups: light and heavy 
smokers (Abala et al., 2005). Those who smoke 20 or fewer cigarettes per day is 
classified as light smokers and those smoking more than 20 cigarettes a day are heavy 
smokers. However, Abala et al (2005) found that smoking independently did not 
influence the smear conversion. 
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Other risk factors are stress, drug abuse, and use of alcohol. TB 
patients also have negative emotions such as anxiety and fear (Marra, Marral, Cox, 
Palepu, & Fitzgeral, 2004). 
 
  Factors influencing adherence to health behaviors  
  Based on the literature review, there are five main factors contributing 
to adherence – patient-related factors, social-economic factors, condition-related 
factors, therapy-related factors, and health system factors. Those factors can be 
contributors and barriers to achieve adherence. However, the adherence from the 
reviewed articles are dominated by adherence to medications, either process or 
outcomes adherence.  
Patients-related factors. These factors have major contribution to 
adherence. It is related to characteristics of patients. Age is one of the variables of 
demographic characteristics. Relationship between age and adherence in TB patients 
is still debatable. It is found that there is no relationship between age and adherence 
(Compton, Bello & Itiola, 2010; Hovell et al., 2003; Kaona, Tubal, Siziya, & Sikaona, 
2004; Wongyou, 2005). However, younger and older patients are more likely to be 
non-adherent (Munro et al., 2007). As age increases, so does chronic illnesses. Older 
patients may be at a higher risk than their younger counterparts for non-adherent and 
subsequent adverse health outcomes due to declining physical conditions of 
advancing age, low literacy level, poor education, and complex regimens (Hayes, 
2005, as cited in Pascucci, Leasure, Belknap, & Kodumthata, 2010).  
Culture is that complex whole which includes knowledge belief, art, 
law, morals, custom, and any other capabilities and habits acquired by man as a 
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member of society (Skolnik, 2008). A study among Latino populations found that 
most of the barriers to medication adherence known were not limited to cultural issues 
(Compton, Haack & Phillips, 2010). Conversely, Munro et al (2007) found that 
particular ethnic group may affect adherence such as in Hispanic patients in the US. 
Marín and Marín as cited in Page (2005) stated that different cultural traditions, 
including race or ethnicity, may encompass a variety of behaviors. In addition, 
bicultural adolescents are positively associated with adherence in regression study 
(Hovell et al., 2003).  Culture is an important issue in health problems including 
adherence since there are many different aspects in each culture. 
Education, as one of demographic variables, has contribution in 
treatment adherence. Education can be education level and literate condition. 
Education level has a positive correlation with adherence (Ai, et al., 2010; Hovell et 
al., 2003). Conversely, it is also found that there is no association between education 
levels and adherence (Kaona, Tubal, Siziya, & Sikaona, 2004; Wongyou, 2005) 
because it was not guaranteed that those patients with high level of education would 
necessarily have good knowledge or awareness about the disease. Some researchers 
also use the term literate to describe education level. Those patients who are illiterate 
are more likely to be non-adherent (Albuquerque et al., 2007; McDonnel, Turner, & 
Weaver, 2001; Xu et al., 2009). 
Knowledge and education seem like synonyms and there is actually not 
much difference between them, but one is interrelated to the other. Correlation 
between knowledge and adherence is still ambiguous. However, some studies found 
positive correlation (Amuha, Kutyabami, Kitutu, Odoi-Adome, & Kalyango, 2008; 
Martin, Grace and Kelly, 2008; Bello & Itiola, 2010). Wongyou (2005) stated that 
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there was no correlation between knowledge and adherence. Specific knowledge that 
is correlated with adherence is required – side effect and its management (Wongyou, 
2005), knowledge about benefits of completing a treatment (Kaona, Tubal, Siziya, & 
Sikaona, 2004), and the general knowledge of TB disease and its treatment (Munro et 
al., 2007). 
Adherence is affected by patient’s belief which could be both positive 
and negative (Munro et al., 2007). Patient’s belief consists of belief and perception 
about treatment regimens, belief and perception about capability, and belief and 
perception about the illnesses. Patient’s belief is related to traditional belief, 
underlying health belief, and contradictory messages. Appropriate health beliefs, such 
as perceived seriousness of diseases, vulnerability to complications, and the efficacy 
of treatment, can predict better adherence (Brownlee-Duffeck et al., as cited in 
Dellamater, 2006). Also, belief in the usefulness and benefits of medication influence 
patients to more likely be adherent (McDonnel, Turner, & Weaver, 2001). Patients in 
Dili prefer to use traditional medicine which is deemed as obstacles (Martins, Grace, 
& Kelly, 2008). This result is similar to many patients who feel that consulting 
traditional healers is the norm and more natural  (Sanou, Dembele, Theobald, & 
Macq, 2004). Likewise, patients who have belief that they are unrecoverable are more 
likely to be non-adherent (Jakubowiak et al., 2008).  
Emotional response related to TB diagnosis is various. It could be 
positive ones such as calm and accepting or negative feelings like shocked/surprised 
or devastated, worried/concerned or depressed, and helplessness (Marra, Marral, Cox, 
Palepu & Fitzgeral, 2004). These negative responses have influenced negatively on 
adherence (Naidoo & Mwaba, 2010). Furthermore, the feeling of shame was a 
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significant predictor for non-adherence based on a study in Russia (Woith & Larson, 
2008). Having negative emotional state influences patients to more likely be non-
adherent (Jakubowiak et al., 2008). Fear and denial of diagnosis have negative 
consequences to adherence treatment as well (Munro et al., 2007). 
Motivation is another patient-related factor. Lack of willingness to 
continue treatment makes patients to more likely be non-adherent (Jakubowiak et al., 
2008). Food incentives that are provided makes patients increase motivation to be 
adherent (Martin, Grace, & Kelly, 2008). In addition, religion and personal motivation 
have positive consequences to adherence (Munro et al., 2007). Therefore, it can be 
concluded that motivation positively affect adherence. 
In conclusion, patient-related factors have contributed to treatment 
adherence among patients with TB. These factors can be protective (enabling) factors: 
education, knowledge, and motivation. On the other hand, patient-related factors 
could be the barriers such as age and psychological factors. However, there are some 
factors that need further clarification, for instance culture and patient’s belief, because 
those factors can be both protective and enabling factors depending  on the contexts. 
In addition, there may be other patient-related factors influencing treatment adherence 
that have not yet been identified by this review. 
Social-economic factors. Social-economic factors mean everything 
related to economic activity and social life. Income, occupation, social support, 
residence and stigma are part of the social-economic factors. Marital status can also 
be considered a social-economic factor; patients who were divorced or widowed were 
more likely to be non-adherent (Xu et al., 2009).  
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Income is an important aspect of daily life especially for individuals 
who need heth care. Income has diverse association with adherence. Demissie, 
Getahun, and Lindtjorn (2003) stated that patients know once they have TB that they 
are going to be affected economically. Sanou, Dembele, Theobald, and Macq (2004) 
stated that there is an unwillingness to spend money on health-related expense since it 
seems more practical and in some cases more important to some patients to spend the 
money to sustain the family’s livelihood instead. Monthly income is not correlated 
with adherence (Wongyou, 2005). However, other studies (Dodor & Afenyadu, 2005; 
Martin, Grace, & Kelly, 2008; McDonnel, Turner, & Weaver, 2001; Xu et al., 2009) 
found that financial difficulties influence patients to more likely be non-adherent. 
Woith & Larson (2008) supported that financial security is a significant predictor of 
medication adherence.  
Income and occupation are interrelated because they contribute to the 
decision of patients whether to continue treatment. Occupation is not related to 
adherence (Wongyou, 2005). However, conflicts between work and treatment 
influence adherence (Munro et al., 2007); required work, dilemma getting treatment 
or going to work could cause non-commitment to treatments. Unemployment and loss 
of employment prevent patients from being adherent (Bogorodskaya et al., as cited in 
Sagbakken, Frich, & Bjune, 2008). Controversially, being a health care worker is 
associated with non-adherence (Maciel, Brioschi et al., 2009).  
Social support includes emotional support, appraisal support, 
informational support, and instrumental support (House as cited in Wongyou, 2005). 
Social support can be provided by peers, family members, community members, and 
others. Social support encourages patients to more likely be adherent (Dodor & 
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Afenyadu, 2005; McDonnel, Turner, & Weaver, 2001; Naidoo & Mwaba, 2010; 
Sagbakken, Frich, & Bjune, 2008). Nasution (2007) found that family support for 
pulmonary TB patients influences significant statistical difference between those who 
were successful and unsuccessful in complying with the DOTS program. Nonetheless, 
Wongyou (2005) found that was no relationship between social support and 
adherence.  
The patients whose residence are in a congregate setting (nursing 
home, shelter, or jail are two times more likely to be non-adherent (Horsburgh et al., 
2010). Moreover, studies found that those patients who are mobile, such as immigrant 
patients, are more likely to be non-adherent (Deiss et al., 2009; Munro et al., 2007; Xu 
et al., 2009). 
Stigma is part of infectious diseases especially for TB and HIV/ AIDS 
patients. It has significant negative association to adherence (Munro et al., 2007; 
Woith & Larson, 2008; Xu et al., 2009). Most patients may hide their diagnosis 
because they feel shame and guilt toward others. 
To sum up, social-economic factors can be barriers in terms of 
unemployed patients, mobile residential status among immigrant patients, and 
negative stigma. However, social-economic factors can be a protective factor for 
patients who have financial and social support. 
Condition-related factors. Condition-related factor means patient’s 
conditions during treatment and the factors are symptoms, side effects, and co-
morbidity. Condition-related factors can also be identified as disease-related factors. 
 The symptoms most complained by patients with TB is weight loss 
and coughing (Bello & Itiola, 2010). Lack of appetite and fever are initial symptoms 
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for TB that influence adherence to treatment (Ai et al., 2010). Martin, Grace and 
Kelly (2008) have found that worsening of patients’ condition is usually the reason 
for non-adherence. Symptomatic improvement on the other hand inspires patients to 
more likely be adherent (McInerney et al., 2007). However, patients feeling better or 
cured makes patients stop taking medications (Cramm, Finkenflügel, Møller, & 
Nieboer, 2010; Kaona, Tuba, Siziya, & Sikaona, 2004; Munro et al., 2007; Shargie & 
Lindtjorn, 2007). In addition, no significant progression makes patients to more likely 
be non-adherent (Sagbakken, Frich, & Bjune, 2008). Therefore, symptoms have a role 
in improving adherence for TB patients and the health care providers should be aware 
of them. 
Side effects are the barriers to achieve adherence. The side effects that 
patients most complain about are dark urine (72.1%), nausea and vomiting (25.4%) 
(Bello & Itiola, 2010). Fatigue and rash are other side effects that make college 
students with TB not complete the treatment (Hess, Goad, Wu, & Johnson, 2009). 
Side effect has negative consequences to adherence (Ai et al., 2010; Munro et al., 
2007; Xu et al., 2009). Severe side effects make patients to more likely be non-
adherent. Conversely, Wongyou (2005) has found that there is no association between 
side effects and adherence. Patients report that healthcare providers often do not 
inform or warn them about side effects and patients also do not mention side effect to 
care providers. These side effect conditions influence patient’s decision to continue 
treatment. Therefore, healthcare providers must pay heed to side effects.  
Co-morbidity is a major predictor for adherence (Ai et al., 2010). HIV 
as co-morbidity with TB is correlated with non-adherence (Maciel, Brioschi et al., 
2009). Patients who also took antiretroviral therapy were significantly associated with 
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non-adherence (Amuha, Kutyabami, Kitutu, Odoi-Adome, & Kalyango, 2008). 
Consequently, having both diagnosis of TB and HIV cause non-adherence for TB 
treatment (McDonnel, Turner, & Weaver, 2001).  
In summary, side effects and co-morbidity can be barriers for treatment 
adherence and symptoms have both enabling and barrier factors depending on the 
context. 
Therapy-related factors. There are several available drugs for TB 
patients such as Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, and Streptomycin. 
However, Isoniazid and Rifampicin are the most essential drugs because they provide 
the best possibility in term of preventing resistant strains from emerging (Girling, as 
cited in Branley, 2009). TB treatment has two phases, namely, initial phase and 
continuation phase. Initial phase takes place for two months and patients take drug 
regimens, for instance, Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol. 
Isoniazid and Rifampicin are given continuously during continuation phase, which 
lasts for four months. Rates of drug resistance are higher among patients who take 
drug regimens three times a week than those who take medicine daily, particularly 
Rifampicin and Isoniazid (WHO, 2009a). 
The shorter Rifampicin regimen shows the better adherence (Hess, 
Goad, Wu, & Johnson, 2009; Li, Munsiff, Tarantion, & Dorsinville, 2010; Trajman et 
al., 2010). Both patients and providers stated that quality of TB medication is poor at 
health care center which in turn makes patients become non-adherent (Munro et al., 
2007). Horsburgh et al (2010) found that non-adherence is related to the 9-month 
Isoniazid regimen. The patients who receive re-treatment are given same drugs as for 
new cases though adding Ethambutol for the full six months (Albuquerque et al., 
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2007). Surprisingly, there is no association between drug regimen and adherence 
(Wongyou, 2005). Costs of treatment also affect adherence to TB treatment (Munro et 
al., 2007). However, some countries provide free TB medications.  
To be brief, health care providers should be aware of treatment-related 
factors when implementing adherence intervention. The need for lower cost for 
treatment and shorter drug regimen will help patients to stay adherent to the TB 
treatment. These aspects can be enabling factors. 
Health system factors. Health system factors consists of relationship 
between patients and health care provider, health services, and access to health center. 
The increasing contact of patients and providers has a positive impact to adherence 
(McInerney et al., 2007; Munro et al., 2007). In addition, Demissie, Getahun, and 
Lindtjorn (2003) found that close relationship between the community members and a 
health centre helps patients gain confidence in health care. Additionally, patients who 
have negative feelings toward health providers are more likely to be non-adherent 
(Jakubowiak et al., 2008). 
Long waiting times or queues, lack of privacy, physical condition of 
the clinics and inconvenient appointment times are problems related to health 
facilities based on patients’ viewpoint (Munro et al., 2007). The study found that 
community-based care is preferred over hospital care, which should be used only for 
the very ill patients. Counseling is one service provided by health care providers to 
patients with TB. Counseling has positive consequences to adherence (Hovell et al., 
2003; Bello & Itiola, 2010). 
DOTS as main intervention has been introduced by WHO since 1995. 
It is found that there is no relationship between DOTS and adherence (Wongyou, 
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2005) possibly because patients are not routinely receiving DOTS. However, some 
studies found that DOTS has a good influence on adherence. Cox, Morrow, and 
Deutschmann (2008) stated that the implementation of the DOTS strategy has 
undeniably improved the outcomes for many millions of patients but treatment 
regimens that can produce good outcomes under best conditions are strictly used in 
high burden settings. DOT supervisor has positive correlation with adherence (Ai et 
al., 2010; Xu et al, 2009).  
Access to health facility depends on patient’s physical condition, 
distance, and available transportation (Munro et al., 2007). In this systematic review 
for ethnography study, it is found that both patients and providers show preference 
toward the nearest clinic because patients can come more regularly (Munro, et al., 
2007). Similarly, adherence is better in urban area than rural area (Johansson, Long, 
Diwan & Winkvist, 1999, as cited in Munro et al., 2007). In addition, private 
practitioners are more accessible to patients. TB clinic too far from home causes 
patients to default on treatment (Shargie & Lindtjorn, 2007). 
Briefly, relationship between patients, healthcare providers, and health 
services as well as short distance of health services contribute to adherence to 
treatment. Some of those factors – age, culture, education level, income, occupation, 
symptoms, side effects, medications, and characteristics of health services – are 
collected in the data demographic form and to be analyzed to determine whether they 
influence the outcomes. Co-morbidity is excluded in this study. Noticeably, 
knowledge, patient’s belief, emotional response, motivation, social support, stigma, 
symptoms, side effects, and DOTS are included in the developed program. 
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  Measurements of adherence behaviors 
  Counting pills that have been taken (Ailinger, Martyn, Lasus & Garcia, 
2010; Clark, Karagoz, Apikoglu-Rabus, & Izzettin, 2007), visit follow-up, (Clark, 
Karagoz, Apikoglu-Rabus, & Izzettin, 2007), urine analysis (Clark, Karagoz, 
Apikoglu-Rabus, & Izzettin, 2007), electronic monitoring, and patient reports are 
tools for measuring medication adherence. Out of the adherence behaviors 
measurements, there is no gold standard for measuring it. In addition, most adherence 
questionnaires are predominated by medication adherence only. Many methods are 
used including patient report, pill count, and electronic using barcode or microchip 
technologies. The best way to measure compliance is using nonjudgmental, 
nonthreatening, and direct questions. 
  Counting pills taken will be analyzed based on the number of pill that 
patients have taken. It is similar with visit follow-up that is based on whether patients 
have gone to the health center for follow ups or not. In addition, Berroa (1998) as 
cited in Hsieh, Lin, Kuo, Chiang, and Su (2008) measured adherence based on 
calculation from the daily observation of the patient’s medication intake. The 
adherence level was above 80% if the patients have fewer than five times of drug 
interruption in a month, on the contrary, the adherence level was less than 80% if the 
there were greater or equal to five times of drug interruption in a month.  
  Electronic monitoring (EM) devices are also used to measure 
adherence. One review studied about the effectiveness of electronic devices and found 
that adherence decreased while the number of daily doses rose (Claxton et al., as cited 
in Dulmen et al., 2007). Moreover, one consistent and robust evidence that has 
increased adherence is by simplifying medication dosage schedules. 
53 
 
Many instruments have been developed to measure adherence using 
patient’s report. These instruments are the UCSF (University of California, San 
Fransisco), the Tuberculosis General Adherence Scale (TBGAS), the Tuberculosis 
Adherence Determination questionnaire, and the Morisky questionnaire. The UCSF 
adherence questionnaire has three categories, namely, reasons for not taking 
medications, number of medication missed, and length of time since missing a 
medication (DiIorio et al., 2003). First, reasons for not taking medications will be 
assessed within 30 days. It has four options (0= never, 1= rarely, 2= sometimes and 
3= often). Possible range for this sub category is 0 to 42 where lower scores will 
represent fewer reasons for missing medications. Second, number of medication 
missed will be asked of patients during the past 4 days. All missing doses for each 
medication will be recorded and the result will be presented by percentage of missing 
doses, calculated by dividing the number of missed dose by the number of prescribed 
dose for each of the past four days. Third, length of time since missing a medication 
will be asked in the first two response categories, (within the past week, 1 to 2 weeks 
ago), the middle two categories (2 to 4 weeks ago, 1 to 3 months ago), and the last 
two categories (more than 3 months ago, never skip medications). There is no 
information about validity and reliability of this instrument. 
  The Tuberculosis General Adherence Scale (TBGAS) is originally 
derived from Sherborne et al (McDonnel, Turner, & Weaver, 2001). This scale has 
five items with 6 Likert scale and alpha reliabilities range from 0.78-0.81. This same 
instrument is also developed for HIV/AIDS patients known as the Antiretroviral 
General Adherence Scale (AGAS). DiIorio et al (2003) stated that the AGAS has 0.70 
the alpha coefficient for responses in the current sample of participants. It is also 
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developed by McDonnel et al (2001) that is used for HIV/ AIDS patients. It has five 
items that assess the ease and the ability of patients during the past 30 days. The 
ratings range from 1 (none of the time) to 6 (all of the time). A total score is computed 
by summing up numbers across the five items after recoding the two negatively 
worded items. A possible score ranges from 5 to 30. 
  Moreover, one study used the Tuberculosis Adherence Determination 
questionnaire that consists of 38 items and 7 scales, which are relevant to 7 theoretical 
determinants of adherence (McDonnel, Turner, & Weaver, 2001). The scales are 
interpersonal aspect of care (IPAC), perceived severity of illness (PSV), perceived 
susceptibility of illness (PS), perceived utility of treatment, subjective norms (SN), 
intention to adhere of treatment plan (INT), and support and barriers to adherence 
(SB). This questionnaire has reliability coefficient of 0.65-0.85 but the sub variables 
of PS, PSV and SB are below 0.7.  
  Morisky, Green, and Levine created Self-Reported Medication Taking 
Scale to measure treatment adherence (Morisky & Dimatteo, 2011). Originally, the 
Morisky questionnaire had four items: 1) Do you ever forget to take your medicine?; 
2) Are you careless at times about taking your medicine?; 3) When you feel better do 
you sometimes stop taking your medicine?; 4) Sometimes if you feel worse when you 
take your medicine, do you stop taking it?. There are two options – ‘yes’ that received 
score 0 and ‘no’ received score 1 – to answer each question. Therefore, the possible 
score is anything between 0 to 4. Patients with higher scores exhibit adherent 
behaviors. Later, Morisky Self-Reported Medication Taking Scale has expanded to 
eight items. The reliability of this tool varied in each research. One study found that 
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Cronbach alpha for this tool to be 0.59 (Morisky, Malotte, Ebin, Davidson, Cabrera, 
et al, 2001). 
  Biswas (2010) designed health behaviors questionnaire for TB patients 
and it had .76 Cronbach alpha coefficients. This questionnaire offers four options for 
answer which are never, sometime, most of time, and all the time. There are six sub-
variables, namely, complying with anti-TB medication, following healthy diet, 
performing physical exercise, maintaining environmental hygiene, preventing disease 
transmission, and avoiding risk factors of TB. This questionnaire will be used in this 
study but the researcher will need to conduct face validity and reliability test due to 
different settings; this study will be conducted in Indonesia but Biswas’s study was 
conducted in Bangladesh.   
  In conclusion, many measurements have been developed to assess 
medication adherence. Every tool has its strength and weaknesses, therefore, and it is 
necessary that the treatment adherence tool and health related behaviors measurement 
have high validity and reliability. 
 
Family-based DOTS Support Program for Patients With TB 
  In order to explain the family-based DOTS support program to patients 
with TB, the concept of family support, family support based on Orem’s theory, 
evidence-based practices of FM DOT supporter for TB patients, and Family-Based 
DOTS support to increase adherence to health behaviors of TB patients are described 
in the following section. 
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  Concept of family support 
  Family support has been defined differently. Terminologically, family 
is a provider of social support called family support. Procidano and Heller, as cited in 
Xiaolian et al (2002), has defined family support as a person’s perceived need for 
moral, emotional, and intimacy support as well as the need for information and 
feedback fulfilled by the family. In addition, family support can be considered as the 
functional component of family system. Family is thus the cornerstone of social 
support (Roach, as cited in Komjakraphan, Isaramalai, Boonyasopun, & Schneider, 
2009).  
   Social support is defined as a reciprocal process that creates positive 
results for the ones receiving support as well as for the ones giving support as both 
have greater feeling of control over their lives (Valla, as cited in Pedro, Rocha, & 
Nascimento, 2008). Support consists of information, either spoken or written or 
materials, that is offered by groups or individuals. Social support has systematic 
contact and emotional effects or positive behaviors. Social support is  
multidimensional and often differentiated into four major dimensions, namely, social 
network, social interaction, perceive or subjective support, and instrumental support 
(Koenig et al., as cited in Hakker-Scheek, Stevens, van Horn, 2004). 
  Finfgeld-Coneet (2005) classified social support based on the 
preference of providers guided by family, friends, neighbors, church members, 
support group participants, and acquaintances. Dimensions of family support system 
are also different. Li et al (2006) divided family support for HIV patients into five 
dimensions, namely, support during the disclosure process, financial assistance, daily 
activities, medical care, and psychological support. 
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  Actually, there are several types of social support: appraisal, 
emotional, informational, and instrumental support (Bullock, 2004; House, 2001, as 
cited in Pedro, Rocha, & Nascimento, 2008). Differently, Finfgeld-Coneet (2005) 
divided social support into two categories, namely, emotional, and instrumental 
support. Emotional needs are correlated to stressors for examples low self-esteem, 
sadness, frustration, anger, loneliness, anxiety, and uncertainty. Instrumental support 
consists of the lack of tangible goods, transportation services, and financial support. 
Family support might influence adherence behaviors through motivation, providing 
information, and feedback. Therefore, the following topic will describe family support 
based on Orem’s theory. 
 
  Family as dependent care agent 
  Orem’s self care deficit nursing theory (SCDNT) consists of three 
interrelated theories, namely, theory of self care, theory of self care deficit, and theory 
of nursing system. Taylor, Renpenning, Geden, Neuman and Hart (2001) stated that 
corollary theory to Orem’s theory of self care is a theory of dependent care. In 
addition, Taylor et al (2001) declared that the foundation of dependent care theory is 
knowledge of self care. Orem (1995, 2001) has introduced the terms dependent care 
(DC), dependent-care agency (DCA), and dependent-care agent since 1970s to meet 
the need to develop SCDNT.  
  DC is a practice in which responsible and mature persons initiate and 
perform on behalf of socially dependent persons for a period of time on a continuing 
basis in order to maintain livelihood and contribute to health and well-being of the 
dependents’ (Orem, 1995, p. 457). Furthermore, Orem (1995) stated that dependent-
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care agency is the power and capabilities to take on dependent care. Orem further 
explained DCA and DC actions as part of her conceptualizations about family (Taylor 
et al., 2001, p.39). Orem (1995) views family in three aspects, namely, basic 
conditioning factors, the setting for infant and children care and for dependent care 
systems associated with health-deviated care, and as unit of care.  
  Family can serve as a dependent care agent, who accepts and fulfills 
the responsibility to know and meet the therapeutic self-care demand those who are 
socially dependent upon them or to regulate the development or exercise as these 
individuals’ self-care agency (Orem, 1995). In order to respond to dependent-care 
demand, dependent care needs to be provided (Taylor, 2001). In addition, dependent-
care system consists of courses and sequence of actions that are performed by the 
dependent-care agent to meet self-care requisite of the dependent person (Orem, 1995, 
2001, p. 457). 
  Orem (1995) views nursing as a helping service involving a person 
who needs help and a person who provides help. There are five methods to fulfill the 
demands, namely, acting or doing for another, guiding and directing, providing 
physical or psychological support, providing and maintaining an environment that 
supports personal development, and teaching.  
  First, acting or doing for others does not apply to a conscious person 
because the helper aids the person to inquire, decide and plan whenever possible and 
with prudence. Second, guiding others requires the guider to make choices and pursue 
a course of action by providing suggestions, instructions, directions or supervision. 
Third, the helper, who has ability to initiate or preserve a task, to think about a 
situation, or to make a decision to provide physical and emotional support. Fourth, 
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providing a developmental environment would motivate the helped to maintain 
appropriate goals and adjust behaviors to achieve results specified by the goals. 
Lastly, teaching another benefit the person who needs instruction to develop 
knowledge or certain skills. The methods can be used separately or in combination. 
  In of dependent care unit for TB treatment and control, a patient is the 
dependent person who has multiple roles as an individual, a person in relationship, a 
recipient of care, and a participant in care. Family consists of family members who 
have roles particularly as persons in relationship and as provider of care. Therefore, 
family should provide support system as dependent-care agent. TB patient who is in 
treatment phase needs to perform several activities. These activities are related to 
achieve the treatment outcome, especially adherence behaviors and successful 
treatment. Family may provide dependent care system wholly compensatory, partly 
compensatory or supportive-educative.  
Dependent care agent’s characteristics may influence the outcome of 
the recipient of care. Most dependent care agents are female.  Studies found the 
difference in ways the dependent care agent’s roles are fulfilled. Women provide 
more intensive care than men do, especially in forms of hours of care and levels of 
care (National Alliance for Caregiving, 2009). Miller and Cafasso (1992) stated that 
gender of caregivers contribute the difference in the involvement and provision of 
care. Mosher and Danoff-Burg found (2004) that female caregivers provide higher 
levels of support than male participants, specifically the emotional support. The role 
of dependent care agent is differently perceived by their age. The younger dependent 
care agents are more unhappy and resentful about their roles than the older caregivers 
(Barusch & Spraid, 1989). Therefore, the dependent care agent’s characteristics must 
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be taken into consideration in this current program by way of matching the age and 
gender of family as DOTS supporter.   
 
  Evidence-based practices of family members DOT supporter 
  Initially, DOT supporter is performed by health care providers. 
Nowadays, there are three types of DOT supporter, namely, health care provider 
DOT, family member DOT, and community health worker DOT. Pungrassami, 
Johnsen, Chongsuvivatwong, Olsen, and Sørensen (2002) found that among those 
supporters who have been assigned as DOT supporters: 11% of healthcare providers, 
23% of community health workers and 35% of family member did not practice DOT. 
Nonetheless, many health care providers did not choose this approach because of 
some specific reasons such as the overload of works, the limited number of healthcare 
providers as well as budget and transportation. There is an idea to involve person 
close to the patients to substitute the health care providers in this role. Family is the 
best support system and most important influences on everyone including TB patients. 
Therefore, DOTS support program has expanded the supporters to include family as 
DOTS supporters as well.  
  The family member DOT supporter is preferred by the TB patients. 
However, TB patients should be informed about the disease, the treatment and DOT, 
and also about selecting a DOT supporter before starting the treatment program. 
Interventions that aim to improve adherence behaviors should have criteria, which are 
educating patients about the importance of adherence, having DOT provider, and 
periodic patient home visits. Family DOT supporter must meet these criteria. Frieden 
and Sbarbaro (2007) stated that treatment observation must be performed by a person 
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who is accessible and acceptable to the patient and is also accountable to the health 
system.  
  The benefit of having family as a DOT supporter is still debatable. The 
Centers for Disease Control and Prevention in the United States suggests that family 
members DOT supporter is risky due to their emotional ties. It may not be a family 
bond but a lack of perceived need. It is clear that family support contributes to 
adherence of TB treatment. Maher (2003) confirmed that family support is obviously 
important for the TB patients. However, since family members are typically not 
neutral or objective about the patient’s health, it is not recommended that family 
members be responsible for observing or recording medication regimens (Farmer, 
2005). Nonetheless, Pungrassami, Johnsen, Chongsuvivatwong, Olsen, and Sørensen 
(2002) found that family bonds in Thailand can benefit general care and psychological 
support. In addition, FM observation will help a patient who has poor performance 
status. 
The studies about family member DOT supporter has been conducted 
in both developed country such as Australia (MacIntyre et al., 2003) and developing 
countries like Brazil (Maciel, Guidoni, Brioshi, do Prado, & Freagona, 2010), Nepal 
(Mathema et al., 2001; Newell, Baral, Pande, Bam, & Malla, 2006), Pakistan (Walley, 
Khan, Newell, & Khan, 2001), Swaziland (Wright et al., 2004), and Thailand 
(Anuwatnonthakate et al., 2008; Kingkaew, Sangtong, Amnuaiphon, 
Jongpaibulpatana, & Anuwatnonthakate, 2008; Okunarak et al., 2007; Pungrassami & 
Chongsuvivatwong, 2002). Appendix A describes further the general information of 
the articles mentioned in this review. 
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  Existing research on effectiveness of FM DOT supporter is dominated 
by epidemiological research and the outcomes for these studies are mostly WHO’s 
outcomes for TB, specifically success rate including cured rate and completed rate. 
However, there is one study using compliance as its outcome that is measured by 
Isoniazid levels in urine (MacIntyre et al., 2003). FM DOT supporter is a household 
member that is trained by TB program staff to properly administer anti-TB drugs and 
to mark the patent’s treatment card after each dose of drug was administered.  
  There are three types of DOT supporter – HCP, FM, and HCV. 
Nonetheless, there is a condition for which patients take medication by themselves 
called SA. HCP DOT has a higher success rate than FM DOT (Anuwatnonthakate et 
al., 2008; Kingkaew et al., 2008; Mathema et al., 2001; Pungrassami & 
Chongsuvivatwong, 2002; Walley et al., 2001; Wright et al., 2004). Conversely, 
Maciel et al (2010) found that FM has a greater success rate than HCP DOT. In 
addition, Newell et al (2006) stated that FM is better than HCV but Pungrassami & 
Chongsuvivatwong (2002) found the reverse result. FM also facilitates higher success 
rate than SA (MacIntyre et al., 2003; Pungrassami & Chongsuvivatwong, 2002, 
Okunarak et al., 2007). On the other hand, Walley et al (2001) mentioned that SA is 
better than FM.  
  Family member DOT supporter has proven to achieve the targeted 
85% of success rate in TB treatment (Anuwatnonthakate et al., 2008; Maciel et al., 
2010; MacIntyre et al., 2003; Newell et al., 2006; Okunarak et al., 2007; Pungrassami 
& Chongsuvivatwong, 2002). However, there are studies that have failed to achieve 
the WHO’s target (Mathema et al., 2001; Kingkaew et al., 2008; Walley et al., 2001; 
Wright et al., 2004). RCT studies found no significant different of success rate 
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between FM, HCP, and SA (Walley et al., 2001); FM and HCP (Wright et al., 2001); 
FM and SA (MacIntyre et al., 2003).  
  Due to many different results of each study, further analysis may help 
understand the variations. Participants’ characteristics in those studies vary in age, 
type of TB, TB history, HIV condition, and MDR. First, there were studies whose 
participants represented all ages (Anuwatnonthakate et al., 2008; Kingkaew et al., 
2008; Mathema et al., 2001; Pungrassami & Chongsuvivatwong, 2002; Wright et al., 
2004): Those who were 15 years and older (MacIntyre et al., 2003; Newell et al., 
2006; Okunarak et al., 2007; Walley et al., 2001), and only adult (Maciel et al., 2010). 
Second, some studies took only pulmonary TB (Anuwatnonthakate et al., 2008; 
Kingkaew et al., 2008) but others took both pulmonary TB  and extra pulmonary TB 
(Mathema et al., 2001; Maciel et al., 2010; MacIntyre et al., 2003; Wright et al., 2004; 
Walley et al., 2001). Third, the studies also differed in aspects of TB history: some 
only involved new TB (Anuwatnonthakate et al., 2008; Kingkaew et al., 2008; Newell 
et al., 2006; Okunarak et al., 2007; Walley et al., 2001), some chose both new and had 
history of previous TB (Wright et al., 2004), and some did not mention TB history at 
all (Maciel et al., 2010; MacIntyre et al., 2003; Mathema et al., 2001). Fourth, HIV/ 
AIDS patients were included in some studies (Anuwatnonthakate et al., 2008; 
Kingkaew et al., 2008; Maciel et al., 2010; Pungrassami & Chongsuvivatwong, 2002) 
though one research did not participate HIV/ AIDS patients (MacIntyre et al., 2003) 
and information for some others were not available (Mathema et al., 2001; Newell et 
al., 2006; Okunarak et al., 2007; Wright et al., 2004; Walley et al., 2001). Lastly, 
MDR patients were not included in the study of Anuwatnonthakate et al (2008) and 
the rest of studies did not state this clearly.  
64 
 
  Validity of each study can be evident in design, sample size, and 
outcomes or instruments. Both cohort (60%) and RCT (40%) are slightly balanced in 
numbers of each study. Subject selection and failure to follow up are major potential 
bias for the cohort design (Mann, 2003). All studies have large sample size and equal 
in each group but few studies might be jeopardized (Anuwatnonthakate et al., 2008; 
Kingkaew et al., 2008). Most studies used success rate as an outcome, that includes 
completed rate and cure rate. The completed rate means the patients who have 
completed all treatments but there is no evidence from laboratory whether patients 
have been cured or not whereas the cured rate refers to the patients who have been 
judged to have recovered from TB based on laboratory test.  
  The exposures and interventions that have been conducted differ in 
every study. There are six cohort studies in this review. Anuwatnonthakate et al 
(2008) provided health education about TB treatment to FM, who observed and 
recorded ingestion of anti-TB medications, as well as the patients who were observed 
by HCP and had to ingest anti TB medications at least five times a week. Similarly, 
Maciel et al (2010) offered training to FM DOT on how to properly assist patients 
with anti TB medications and also to record the patients’ treatment cards after every 
dose was administrated while at the same time HCP instructed the patients to attend 
the outpatient clinic daily to take medications and marked in patients’ treatment cards. 
HCP followed up with the patients who did not attend by making routine contact or 
trace. Mathema et al (2001) stated that every group (HCP, FM/ HCV, and SA) serves 
as patients’ supervisor during the treatment. In the same way, Pungrassami and 
Chongsuvivatwong (2002) had HCP, FM, and HCV as supervisors on the first day of 
treatment patients usually switch or select a different supervisor during the treatment. 
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Okunarak et al (2007) studied a center-based group who was observed by HCP, a 
family-based group who was observed by family members, and a community-based 
group who was observed by the HCV. There is no information regarding the 
exposures of each group. Kingkaew et al (2008) provided counseling on TB to the 
patients and relatives who live with the patients. FM group took weekly medication 
including its remnant to make sure the tablets were completely consumed. HCP group 
was given medication by HCP once daily. 
  The RCT studies’ interventions also vary. First, MacIntyre et al (2003) 
compared FM and SA. A patient chose FM and the FM then receives education and 
training about watching the patient swallowing the anti-TB drugs daily and recording 
it. The recording was collected every fortnight. FM was followed-up by telephone so 
they were kept motivated and also to check progress and problems. SA was given 
standard care and the patients were required to record pill taking themselves. All 
patients paid a monthly clinic follow-up visit where they took the medications. 
Second, Newell et al (2006) studied two groups, which were HCV and FM. HCV 
group was supervised by a female community health volunteer or a village health 
worker and the medications were given to the supervisor monthly. Patients who 
discontinued treatment were traced by HCV. FM group was supervised daily by a 
household member, who is selected by the patient. The medications were given 
weekly to the supervisor. Government workers conducted dedicated tracing on 
patients who discontinued treatment. 
  Third, Wright et al (2004) studied HCV and FM DOT. HCV received 
training about monitoring the patients’ daily medication intake, reminding the 
patients, and recording the adherence. FM was nominated by the patient and received 
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training to perform the same roles as HCV. Patients from FM group visited the HCV 
weekly to monitor side effects, adherence, and for general health education. The 
defaulter patients from both groups were reported to the diagnostic center. Fourth, 
Walley et al (2001) studied CHP, FM, and SA. CHP informed patients to attend the 
clinic six times a week during the intensive phase and patients continued to be self-
administrated for the continuation phase and collected the medications fortnightly. 
FM was chosen by the patient and collected the medications every fortnight. FM 
received training on recording the medications, the importance of observing drug 
taking and encouraging the patient to complete the treatment. SA took medications 
fortnightly from the most convenient health facility.  
  Those studies were conducted in different settings which could vary 
the results. The meaning of family may differ in every country. The developed 
country like Australia has a completely different culture from the developing 
countries in Asia and Africa. There is usually a stronger bond within a family in 
developing countries when compares to developed countries, particularly collectivity 
and individual approach.   
  In sum, FM DOT supporters may not perform their duties properly 
even though they have been trained by a healthcare provider. However, no study 
mentioned clearly what the contents of the training were. Obviously, FM DOT 
supporters would not perform well because they are not medical professionals. 
Therefore, family is required to be prepared efficiently before being assigned as DOT 
supporter. The family-based DOT supporter program may help to improve adherence 
behaviors in TB patients. 
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 Family-based DOTS support program in increasing adherence to 
health behaviors 
  Family-based DOTS support program is designed to help TB patients 
to improve adherence behaviors and achieve treatment success. Hsieh, Lin, Kuo, 
Chiang, Su, et al (2008) stated that direct daily observation, health education, and the 
long-term follow ups are the golden triangle in insuring TB patient’s adherence. The 
efficacy of family member DOT supporter has been recently conducted in a 
significant number of research which has pacified an increasing need for the 
guaranteed value of this approach. Since none of the family-based DOTS support 
programs has been standardized, the researcher would like to design a protocol for 
this program to increase adherence behaviors patients with TB. Adherence behaviors 
reflect the active role of the patients in self-management during treatment and the 
importance of cooperation between patient and provider (Sumartojo, as cited in 
Anastasio, 1995, p. 12). The researcher will design the protocol of family-based 
DOTS support program consisting of four methods: helping, inspired by Orem (1995, 
2001), guiding and directing; providing physical and psychological support; providing 
and maintaining an environment; and teaching. 
  Since none of the previous studies has used Orem’s theory in 
increasing adherence to health behaviors in patients with pulmonary TB, the 
researcher would like to adopt Orem’s theory in other chronic diseases. However, 
most of the studies utilized an individual approach instead of family involvement in 
their interventions. Appendix B provides general information regarding studies of 
supportive educative program in other diseases.  
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  The characteristics of the study include selected population of the 
study, setting of the study, intervention approach, and design. The supportive 
educative program has been used for variation of diseases, including hypertension 
(Kauric-Klein, 2011), COPD (Kamsee, 2004), asthma (Kiatthitinun, 2005), TB 
(Ngamtrairai, 2003), chronic heart failure (Rau, 2000), breast cancer (Wonghongkul 
et al., 2008), diabetes (Mohamed, 2005), children with long-term tunneled catheter 
(Sirireung, 2005), premature infants (Taya, 2004), pregnant with premature labor pain 
(Wongtongchareon, 2003), and metabolic syndrome (Lauren, 2007). The studies were 
conducted in different countries such as Malaysia (Mohamed, 2005), Thailand 
(Kamsee, 2004; Kiatthitinun, 2005; Ngamtrairai, 2003; Sirireung, 2005; Taya, 2004; 
Wonghongkul et al., 2008; Wongtongchareon, 2003), and the United States (Kauric-
Klein, 2011; Lauren, 2007; Rau, 2000). The interventions were given to the patients 
(Kamsee, 2004; Kauric-Klein, 2011; Lauren, 2007; Mohamed, 2005; Ngamtrairai, 
2003; Rau, 2000; Wonghongkul et al., 2008; Wongtongchareon, 2003) and family as 
caregiver (Kiatthitinun, 2005; Sirireung, 2005; Taya, 2004). The studies used quasi-
experimental design (Kamsee, 2004; Kiatthitinun, 2005; Lauren, 2007; Mohamed, 
2005; Ngamtrairai, 2003; Rau, 2000; Sirireung, 2005; Taya, 2004; Wonghongkul et 
al., 2008; Wongtongchareon, 2003) and RCT studies (Kauric-Klein, 2011). 
  The outcomes of the studies are self-care practices (Kamsee, 2004; 
Mohamed, 2005), self-care behaviors (Kiatthitinun, 2005; Kauric-Klein, 2011; 
Lauren, 2007; Ngamtrairai, 2003; Taya, 2004), medication self-cares (Rau, 2000), 
dependent-care behaviors (Sirireung, 2005), quality of life (Wonghongkul et al., 
2008), and self-care agency and outcome of pregnant (Wongtongchareon, 2003). 
Most studies have shown positive results indicating that the educative-supportive 
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program facilitates significantly better self-care practices (Kamsee, 2004; Mohamed, 
2005), self care behaviors and severity of asthma (Kiatthitinun, 2005), blood pressure 
self-regulation and blood pressure self-care behaviors (Kauric-Klein, 2011), level of 
knowledge, self-efficacy expectation, and self-care behaviors (Ngamtrairai, 2003), 
dependent-care behaviors and the occurrence of complications (Sirireung, 2005), 
maternal self-care behaviors and health outcome (Taya, 2004), and self-care agency 
and pregnant outcome (Wongtongchareon, 2003). Conversely, the study of Rau 
(2000) found that the supportive educative program had no significant statistical 
difference on medication self-cares and hospital readmission. Similarly, 
Wonghongkul et al (2008) found that there was no significant difference of quality of 
life between experimental group and control group. Unfortunately, the mean of 
quality of life in experimental group did not increase after receiving the supportive 
educative program. Likewise, Lauren (2007) found that there was no significant 
difference in weight loss or perception of self care between the two groups. 
  Some studies only provided abstract so the researcher has no complete 
information about the interventions that have been done (Kiatthitinun, 2005; Taya, 
2004; Wongtongchareon, 2003). The intervention was provided in the first day of 
hospitalization and maintained two weeks after discharging at patient’s home 
(Kamsee, 2004). Kauric-Klein (2011) provided education session and 30 days of post 
intervention for follow ups, reinforcement for goals met and problems solving were 
provided if goals were not met in the intervention group that had had 12 weeks of 
intervention. On the other hand, the control group received standard care that 
consisted of blood pressure monitoring and medication adjustment by health care 
providers weekly. Ngamtrairai (2003) provided information about TB, group 
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discussion, self-care behaviors guidance, providing psychological and economic 
support and coordination for supportive environment. In order to increase self-care 
practice, the supportive-educative nursing system was given in three sessions. 
Sirireung (2005) provided extra supportive educative nursing systems and a handbook 
for each of the patients in experimental group. Rau (2000) compared the intervention 
group that received several helping techniques (guiding, teaching, and support) in 
self-management and weekly visits for 8 weeks while the placebo group that received 
health promotion education regarding immunization for adults, ways to decrease risk 
for falls, general nutrition, normal aging, and general health maintenance. However, 
there was a significant statistics indicating improvement of medication self-cares 
within the experimental group (p < 0.05). Mohammed (2005) provided the 
interventions including five methods of helping (teaching, guiding, supporting, 
providing a healthy environment) and a handbook about dietary control, exercise, 
medication taking, stress management, & personal hygiene. 
  Based on the studies that have used Orem’s theory as theoretical 
framework particularly supportive educative nursing system, the researcher would 
like to design a supportive educative program that is suitable for TB patients in hope 
to increase adherence to health behaviors. Four of the helping techniques will be used 
in this study, namingly, teaching, guiding and directing, supporting, and providing 
environment.   
  As aforementioned, teaching methods refers to increase knowledge and 
belief about TB for both patients and their families. Symptoms and side effects 
managements belong to disease and treatment factors in this study. Additionally, there 
are few possible barriers that may happen during treatment process, by guiding and 
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directing will help patients, through help of the family, to maintain adherence 
behaviors. Risk factors and preventing disease treatment are also important points so 
by providing both psychological and physiological support the patients will stay 
adherent. Finally, motivation is also very important for TB patients and so needs to be 
provided regularly.   
  To sum up, in order to improve adherence to health behaviors, the TB 
patients need to have a good understanding about what the treatment entails, and how 
health providers expect them to modify their behavior. They also need to understand 
how to control aspects of their behavior.  Patient, clinic or treatment barriers to 
adherence must be identified and modified. Patients require direct and continual 
feedback on their performance in order to reinforce positive behavior modification. 
The social support for the patient during treatment proves to be beneficial. These 
aspects are provided through four methods of helping – teaching, guiding and 
directing, providing physical or psychological support, and providing and maintaining 
an environment. The influencing factors (i.e., age and gender) of DOT supporter may 
contribute to the implementation of the program.  
 
Summary 
  The literature review revealed valuable information for the 
development of family-based DOTS support program to enhance adherence to health 
behaviors among patients with pulmonary TB. TB remains a public health concern 
worldwide and also in Indonesia. Adherence has been defined differently in many 
studies. Obviously, adherence in this study is parallel with self-care deficit nursing 
theory which defines adherence as part of self-care behaviors. Health behaviors are 
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important for pulmonary TB patients in achieving successful TB treatment. Five 
major factors have been identified: patient-related factors, social-economic factors, 
condition-related factors, therapy-related factors, and health system factors. Of those 
factors, knowledge, patient’s belief, emotional response, motivation, social support, 
symptoms and side effects of TB, and DOTS are taken into account in developin the 
program. The existing tools of measuring adherence have been reviewed and the 
researcher recognizes that the tools have limited validity and reliability.  
  The findings of the literature review discover that DOTS has achieved 
success in TB treatment. DOT supporter as part DOTS program can be health care 
provider, family, and community health worker. The family as DOT supporter is 
considered as the best supporter. However, the findings of the effectiveness of family 
as DOT supporter vary. The variation of findings possibly occur because of the 
difference in subject’s characteristics, i.e., age, type of TB, TB history, co-morbidity, 
and MDR and research methodology, i.e., study design (cohort and RCT), sample 
size, and the outcomes and its tools. The interventions and exposures may also 
influence the results. The family has been trained by the health care provider before 
serving as DOT supporter but appropriate DOTS program is required so to ensure 
efficient and sufficient trainings be delivered to the family. 
  Self-care deficit nursing theory is used to guide the program. Family 
support has been defined by Orem’s SCDNT theory as dependent care agent, who 
fulfills the responsibility to know and meet the therapeutic self-care demands. The 
nursing system used for TB patients is supportive educative program. The review of 
effectiveness of supportive educative program found that this program has achieved 
better outcomes, i.e., self-care behaviors and self-care practices of chronic diseases 
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and conditions. Most studies used helping methods – teaching, guiding, supporting, 
and providing environment. Differently, in the present program, the researcher would 
like to combine the helping methods and self-care operations, estimative operation, 
transitive operation, and operative operation. Therefore, it is important to conduct a 
study to investigate the effect of family-based DOTS support program on adherence 
to health behaviors in Indonesia. 
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CHAPTER 3 
RESEARCH METHODOLOGY 
 
  This chapter presents research design, variables, setting, population 
and sample, sampling procedure, research instrument, validity and reliability of 
instruments, translation of instruments, ethical consideration, data collection methods, 
and data analysis. 
 
Research Design 
  The design of this study was a cluster randomized design with two-
group: pre-test and post-test design. This study aimed to examine the effects of the 
family-based DOTS support program on adherence to health behaviors among 
patients with pulmonary Tuberculosis. The control group received routine care 
program and the experimental group received the family-based DOTS support 
program and routine Tuberculosis care. The research design is depicted as follows: 
 Pre-test  Post-test 
Control group R O1 O2  
Experimental group R O1 X O2 
 
R refers to cluster randomization for the community health centers 
O1 refers to the baseline data (pre-test score) of adherence to health behaviors  
X refers to the family-based DOTS support program  
O2 refers to the score of adherence to health behaviors after receiving family-based 
DOTS support program (post-test score) 
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Variables 
  The independent variable in this study was the family-based DOTS 
support program while the dependent variable was adherence to health behaviors 
among patients with Tuberculosis. The factors that might influence adherence to 
health behaviors were controlled by matching technique and using statistical 
approach.  Matching technique was used on selection of family DOT supporters to 
control the potential confounding variables of age (±5 years) and gender (female and 
male). Data regarding patients-related factors (age, culture, education, knowledge, and 
emotional response), social-economic factors (income, occupation, and residence 
area), condition-related factors (symptoms, side effects), therapy-related factors 
(medications), and health care provider and health system factors (characteristics of 
community health centers) were collected and taken into account for statistical 
control. In addition, some factors were restricted through the following inclusion 
criteria: age, type of TB, type of registered group, and co-morbidity. 
 
Setting 
  The cluster randomized trial, either the experimental group or the 
control group, was conducted in community health centers in Bandung, a capital city 
of West Java Province, Indonesia. Bandung, a large city with population density of 
14,228 people in one kilometer squares, has 63 community health centers. The 
community health centers that had high number of patients with Tuberculosis were 
chosen. Of 63 community health centers, 10 health centers participated in this study. 
There was no equal number of patients in each of the participating community health 
centers. Regardless of minor variations, community health centers provided TB 
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diagnosis and TB treatment by having DOTS standard in their practices.  
  DOTS consisting of five components has been applied in Indonesia. 
DOTS is mostly operated by the community health centers. The services include the 
surveillance, diagnosis and the treatment of TB.  One component of DOTS 
implementation is to engage family as DOT supporter. Family is assigned as DOT 
supporter at the starting point of treatment and health education is provided to gain 
understanding about TB care. The health education is mainly provided to the patient. 
The DOT supporters could receive the health education if they accompany the patient 
at the starting point of treatment. No routine follow up or evaluation of the DOT 
supporter performance is conducted by the community health centers. Patient, who 
has been diagnosed of TB, visits a community health center to take the medications 
and regular checkup every week in the intensive phase and every two weeks in the 
continuation phase. The service of TB care includes the sputum investigation exam on 
the second month, the fifth month, and the sixth month. Though services are free of 
charge, patients must make a contribution of less than 1 USD per visit.  
 
Population and Sample 
  Patients with pulmonary Tuberculosis and their DOT supporters 
residing in the participating the community health centers in Bandung, Indonesia, 
were included in the study population. The subjects of this study consisted of 60 
pulmonary TB patients and their 60 families who met the inclusion criteria and also 
agreed to participate.  
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  Sample size 
  The sample size of this study was estimated by using power analysis 
and the effect size was determined by calculating the effect size of the findings 
previous study. Mohamed (2005), who used the supportive-developmental nursing 
program to improve self-care practices of patients with type 2 diabetes, found that the 
subjects who received the supportive-developmental nursing program demonstrated 
significantly greater self-care practices (M = 193.66, SD = 21.25) than those subjects 
who received standard care (M = 134.50, SD = 37.83). According to Cohen (1998), 
the required sample size for significant criterion is .05, power = .80, and effect size d 
=1.92 (Appendix C) exceeded a ”d” = 1.4. However, the Mohamed’s study was 
different from the present study in terms of population and intervention approach. 
Therefore, the researcher used large effect size (d = .80) for sample estimation and 
yielded the necessary sample size of 26 subjects per group. Increasing the number of 
sample size in cluster randomized trials was needed to prevent any bias (Graudeau & 
Ravuqal, 2009) and for statistical analysis purposes (Campbell, Elbourne, Altman, 
& CONSORT Group, 2004). Keeping these aspects in mind, the researcher added 
about 20% subjects of each group so there were 30 subjects in each group and a total 
of 60 subjects. In Addition, Cohen (1988) stated that 30 participants per group should 
lead to about 80% power to detect difference. 
 
Inclusion criteria 
  The inclusion criteria to identify eligible subjects were: 1) must be 
older than 15 years of age; 2) had confirmed diagnosis of pulmonary Tuberculosis and 
was at the intensive phase of TB treatment; 3) was a new case of Tuberculosis 
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treatment; 4) no diagnosis of MDR-TB; 5) no other underlying diseases with long-
term treatment, namely, diabetes, hypertension, chronic renal failure, and others; 6) no 
diagnosis of HIV/ AIDS; and 7) able to write and read Indonesian language. Since 
this study involved a family member to serve as a dependent care agent, the inclusion 
criteria of eligible family members were: 1) must be selected as DOT supporter by the 
patient; 2) must be 18 years or older; 3) live with the patient; and 4) able to write and 
read Indonesian language.  
  During the study, the patients were excluded if they: 1) developed a 
severe condition that caused them to discontinue the participation in the study or 
unable to perform health behaviors activities and 2) did not complete the study up to 
the post-test data collection. Fortunately, none of the recruited subjects was excluded 
from this present study.  
 
  Sampling Procedure 
  The study sample was taken from the participating community health 
centers using lottery. The community health centers were assigned by lottery to either 
the experimental group or the control group. The potential subjects and their families 
who meet the inclusion criteria were approached by a nurse to ascertain their interest 
in this study. The families as DOT supporters were matched based on age (± 5 years) 
and gender (male or female). Then, the researcher explained the purpose of the study, 
procedures, risks, benefits, and confidentiality. The researcher then obtained verbal or 
written informed consent (Appendix D). The researcher allowed the patients and their 
families to withdraw from the study at any time without penalty. The sampling 
procedure proceeded in this method until 60 subjects and their 60 families were 
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assigned to one of the two groups (30 subjects/ group). Since the subjects and their 
families of the control group and experimental group lived in different areas 
surrounding responsible community health centers, the chance of interaction between 
the two groups was slim. 
 
Instrumentation 
  There were two instruments — family-based DOTS support program 
and data collection instruments, including the demographic data form, and the 
Tuberculosis adherence to health behaviors questionnaire. Each instrument was 
described as follows: 
 
  Family-Based DOTS Support Program 
  The family-based DOTS support program was developed based on 
SCDNT by Orem (1995; 2001) by the researcher. This program covered four helping 
methods – teaching, guiding and directing, supporting, and providing environment –
and three self-care operations: estimative, transitive, and operative operations 
(Appendix E). The duration of program was five weeks. This program included a 
handbook to guide Tuberculosis patients to maintain adherence to health behaviors at 
home (Appendix F). The contents of the handbook included definition of 
Tuberculosis, signs and symptoms, risk factors, tuberculosis treatment, and health 
behaviors necessary for recovery and prevention of TB transmission.  
  During the first week (T1), every subject and his/ her family received 
three intervention sessions as follow: 1) estimative operation using teaching technique 
to cover cause and impacts of TB, TB and medications/ diet/ exercise, and 
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management of symptoms and side effects of medications; 2) transitive operation 
using teaching, guiding, supporting, and providing environment for decision on care 
activities, providing choices, and discussing the benefits and limitations of each 
choice; 3) productive operation using teaching, guiding, supporting, and providing 
environment for making action plan and evaluation of the implementation (Appendix 
D). Estimative operation was performed after the subjects signed informed consent 
and was conducted for about one hour. This session involved not only the patients but 
also their DOT supporters. Teaching method was employed to provide knowledge 
about TB overview and health behaviors. In order to facilitate patient’s understanding, 
spoken and written explanations were provided using booklet and leaflet. In addition, 
the patients and their DOT supporters had opportunities to ask any questions. At the 
end of the session, the researcher ensured clear understanding by asking the clients 
about each provided topic. TB overview included TB disease, TB symptoms, impacts 
of TB, and importance of adherence to health behaviors. Medications, diets, exercise, 
health environment, transmission, and risk factors were main topics of TB health 
behaviors adherence.  
  Transitive and productive operations were conducted within four days 
after estimative session (M = 2.17 days, SD = 1.15). Both operations lasted about one 
hour. Making judgments and decisions were main activities of transitive session. The 
current health conditions and each health behavior were discussed and any barriers/ 
facilitators were explored. Patients and their families were provided with any 
obstacles that could possibly happen during the implementation of each health 
behavior which helped them explore any alternatives and prepare to overcome those 
difficulties. The researcher ensured and provided psychological support as well as a 
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warm environment in order to make the clients feel at ease about revealing the 
problems and seeking solutions for them. Balance sheet for decision making to 
identify the advantages and disadvantages of each behavior was filled by either the 
patients (n = 21) or their DOT supporters (n = 9) to help them with decision making in 
implementing each health behavior. The characteristics of the subjects who received 
help from their DOT supporters in filling this sheet were three female elder patients, 
five male patients, and a young female patient. Operative operation continued upon 
the completion of transitive operation.  
Plan of action was the main outcome during operative operation. Both 
patients and their DOT supporter participated in creating the action plans. Every 
health behavior was included to the action plan form that was filled by either the 
patients (n = 21) or their DOT supporters (n = 9). Action plan consisted of goals and 
the actions indicating when, where, how, and how often. Suggestions and 
recommendations were provided to assist the clients. Conducive environment and 
psychological information support were offered in this operation. Lastly, evaluation 
record form was explained and the patients were asked to fill this form every day in 
order to help them measure how they achieved adherence of each health behavior. 
They put (√) in the record form if they had followed the action plan, for each health 
behavior, completely.  
  On the second and the third week, the researcher conducted telephone 
follow up. The researcher asked about the activities and the barriers experienced by 
the patients. In addition, evaluation of implementation was performed whether the 
action plan was to be revised or continued. Every patient and his/ her DOT supporter 
were asked and reminded to fill out evaluation record form.  
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On the fourth and the fifth week, the researcher conducted face-to face 
follow up with the patient and his/ her family. These follow ups aimed to assess the 
patient’s current adherence to health behaviors as well as implementation of action 
plan and also to identify its barriers and make further plans in maintaining and 
improving his/ her adherence to health behaviors. Positive feedback, encouragement, 
and supportive environment were created during this session. Five patients who did 
not complete the record form were three females and two males, three of them had 
been helped by their DOT supporters in filling out balance decision making sheet and 
action plan form. The duration of each follow-up visit depended on patient’s 
conditions and needs. Time spent with patients who asked more questions or had 
complicated conditions were typically longer than those who had no significant 
problems. Finally, a post-test of the patient’s adherence to health behaviors was 
conducted.  
 
  The demographic data form (DDF) 
  The DDF was developed by the researcher. It consisted of three 
components, including patient information and patient health-related data, family 
information, and DOT supporter (Appendix G).  This form was completed by the 
patients. Patient information and patient health-related data composed of age, gender, 
marital status, religion, ethnic, occupation level of education, income, health 
insurance, other health problems, length of treatment, length of enrollment and 
treatment, distance between house and community health center, the symptoms, types 
of treatment received, and list of problems after taking medications. Family 
information included family history for caring TB patients, family history for caring 
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chronic disease patients, family members with chronic disease, family type, 
vulnerable people, and family size were collected. Data about DOT supporter 
information included age, gender, marital status, religion, occupation, education level, 
and caregiver during treatment. Lastly, health related data comprised of medications, 
diet, physical activity, environmental hygiene, disease transmission, and risk factors.  
 
The Tuberculosis adherence to health behaviors questionnaire 
(TAHBQ) 
  The modified version of TAHBQ originally developed by Biswas 
(2010) was used. The reliability of this questionnaire revealed in Biswas’s study 
yielding Cronbach’s alpha coefficient of .76 internal consistency. There were 31 items 
and six sub-scales, namely, complying with anti-TB medications, following healthy 
diet, performing physical exercise, maintaining environmental hygiene, preventing 
disease transmission, and avoiding risk factors of TB (Appendix H). The response 
format is a 4-point Likert scale [never (1), sometime (2), most of the time (3), and all 
the time (4)]. The total score ranges from 31 to 124. Higher scores were considered as 
higher level of adherence to health behaviors. Additionally, the level of adherence to 
health behaviors was divided into three levels, namely, low (31.00 - 62.00), moderate 
(62.01-93.00), and high (93.01-124.00). 
  Due to overlapping statements and some behaviors were not included 
in the original questionnaire, the researcher modified this instrument to achieve the 
best fit with health behaviors of TB. In the modification process, the researcher 
discussed with advisors and experts to identify unmatched items and figured out the 
most suitable behaviors. The modifications made to this instrument were one item of 
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following healthy diet and maintaining environmental hygiene subscales was deleted 
and one item of maintaining environmental hygiene and avoiding risk factors 
subscales was added.  
 
  Translation of the instruments 
  The instruments were translated using back-translation technique in 
this study (Brislin, 1970). The instruments were translated from the original English 
version to an Indonesian version by an Indonesian bilingual translator. Subsequently, 
Indonesian version of the tool was translated into an English version. Finally, the two 
English versions were examined for comparability of language and similarity of 
interpretation. A third translator then assessed any discrepancies and adjusted the 
identified differences between the original version and the back-translated version by 
changing the words. The items no 11 and 25 were adjusted in order to be understood 
by the patients. 
 
  Validity of the instruments 
  The DDQ and the TAHBQ were validated by three experts, each of 
whom was from Faculty of Nursing Prince of Songkla University, Yala Hospital, and 
Faculty of Nursing Universitas Padjadjaran, Indonesia. In addition, the family-based 
DOTS support program, particularly the guidelines, contents, and materials, were 
evaluated by these same experts. These contents were revised based on the experts’ 
comments and recommendations. The experts suggested the followings: 1) to rewrite 
the sentences, delete one item, and add two more items in adherence to health 
behaviors questionnaire; 2) to add particulars contents in the interventions (i.e., health 
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and TB belief; hazardous of drug resistance, and stigma of TB); and 3) to revise the 
evaluation record form and provided example in the booklet. 
 
  Reliability of the instruments 
  The TAHBQ was examined for its reliability in 20 patients with 
pulmonary Tuberculosis. The Cronbach’s alpha was used to determine the internal 
consistency reliability of the adherence to health behaviors questionnaire. The results 
showed that the Cronbach’s alpha coefficient of Indonesian adherence to health 
behaviors questionnaire .78, which is slightly higher than previous Cronbach’s alpha 
at .76. This result was adequate and accepted. 
  
Pilot Study 
  A pilot study was conducted. It aimed to test the feasibility of the 
designed intervention (Polit & Beck, 2008). The pilot study was done with two 
patients who met the study inclusion criteria. The patients and their families received 
a brief, one week of the family-based DOTS support program, with a two-time 
telephone follow up and one face to face follow up. 
  Generally, the program was applicable in this present study. There was 
no problem in understanding and applying the intervention and the booklet as well as 
fulfilling the evaluation form. However, the difficulty was found in terms of 
appointment for telephone follow up particularly for patients who had no mobile 
phone. Therefore, further appointment was needed to do telephone follows-up by 
asking the patient to send message for arranging time for telephone follow up.  
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Study Protocol and Data Collection Procedures 
The data collection was performed at each subject’s house or at the 
community health centers. Two phases – preparation phase and implementation phase 
– were conducted as follows: 
  Preparation phase 
  The preparation phase consisted of the following steps: 1) obtaining 
official approval from Faculty of Nursing Prince of Songkla University; 2) attaining 
official permission for data collection from Bandung’s local health department office; 
3) preparing the materials and the questionnaire packages including the informed 
consent; 4) testing the validity and reliability of the instruments; 5) recruiting two 
research assistants (RAs) who had at least a bachelor degree of nursing; 6) conducting 
training for the research assistants; and 7) conducting the pilot study.  
The RAs had responsibility to do pre-test and post-test data collection. 
There were three steps of training for RAs. First, presenting the objectives, protocol 
and instruments were used in this study. Second, providing explanation about the 
RA’s role and responsibilities in collecting the pre-test and post-test data were 
conducted. Lastly, the researcher and the RAs reviewed each questionnaire as well as 
the method to complete the questionnaire in detail. The RAs asked about any 
confusion and the researcher clarified them during this process to ensure that the RAs 
would be able to answer any questions from the patients during data collections. RAs 
reported that some items (item no 16, 17, 23, 25, 27, 28, and 29) were confusing. 
Therefore, they were prepared to be mindful of these particular items. Clear 
explanations and particular examples were provided to both RAs. 
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  Implementation phase 
  The eligible subjects were approached and asked about his/ her interest 
and willingness to participate in the present study. They signed informed consent 
form or provided verbal consent if agreed to participate in the study. No prospective 
patients of the control group refused to participate in this study, however, one 
prospective male patient of the experimental group refused the participation because 
he had not time. The researcher made an appointment to meet with the patients in the 
experimental group who attended the family-based DOTS support program. The RAs 
helped the patients to complete the questionnaires. Patient’s adherence to health 
behaviors was assessed two time points, once before intervention (T1) and at the fifth 
week (T2) of treatment. 
  Subjects in the control group were asked to complete the DDF and 
TAHBQ. Patient’s adherence to health behaviors was measured at T1 and T2. After 
completing the questionnaire on the fifth week, all patients received the booklet about 
Tuberculosis and a short-course orientation on family-based DOTS support program. 
Patients were allowed to ask any questions during the meetings or later via telephone. 
Five subjects of the control group communicated with the researcher via telephone 
regarding the Tuberculosis and their conditions.  
 
Ethical Consideration 
  Concerning the rights of human subjects, this study earned an approval 
from the Ethics Committee of Faculty of Nursing, Prince of Songkla University, 
Thailand, and was granted a permission from Bandung Local Health Department, 
Indonesia. The nurses in the community health centers introduced the researcher and 
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RAs to the potential subjects of this study. All subjects participated in this study 
received verbal and written explanation about the study. In addition, patients were 
informed that they were assigned into two groups, namely, the experimental and the 
control group. A consent form was given based on the subject’s interest. Signed 
consent form or verbal consent to participate were used as forms of consent. The 
researcher assured the subjects that their participation was voluntary and that they 
could withdraw their participation at anytime without any negative consequences to 
the care being provided to them. Moreover, the researcher’s contact information (i.e., 
telephone, and address) was provided to them. All of their information was kept 
confidential. Any results of this study were presented in an aggregate form and for 
academic purpose only. Additionally, there was no risk in participating in the study. 
The patients in the control group received the handbook about Tuberculosis care 
management after all the data collection was completed. 
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Figure 2. The Implementation phase of data collection procedures 
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Data Analysis 
Data were analyzed using descriptive and inferential statistics to 
answer the research questions. The demographic data of the subjects were analyzed 
and described in frequency, percentage, mean, and standard deviation (or median and 
quartile deviation). In addition, mean and standard deviation (or median and quartile 
deviation) were used to compare adherence to health behaviors before and after 
intervention. Chi square, the Fisher’s Exact test, continuity correction, and 
independent t-test were applied to test the equivalence of the proportion or mean 
difference of demographic data between the experimental group and the control 
group.  
The researcher examined the assumptions of normality and 
homogeneity of variance of the data sets of adherence to health behaviors. Since the 
total scores of health behaviors adherence aligned with the assumptions, Paired t-test 
was used to test the difference of adherence to health behaviors within the control 
group and the experimental group. Independent t-test was used to test the difference 
of adherence to health behaviors between the experimental group and the control 
group. The level of significance was set at p < .05. Two variables of demographic 
characteristics (i.e., length of treatment and joint pain) were found to be significantly 
different; ANCOVA was performed to test the effectiveness of the program by taking 
them as the covariance variables. Before conducting ANCOVA, the assumptions were 
assessed (Rutherford, 2001) and the results showed that there was not significant 
interaction between the covariates and the factor (independent variable) in the 
prediction of dependent variable. The underlying assumption of homogeneity variance 
for the ANCOVA was met. Therefore, ANCOVA was applied in this study. 
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CHAPTER 4 
RESULTS AND DISCUSSION 
 
This chapter presents and discusses the study’s results and findings. 
The subjects’ characteristics, both health-related, and symptoms characteristics, are 
described, followed by family and DOTS supporters’ characteristics. Next, the 
adherence to health behaviors of the subjects in the experimental and the control 
groups are illustrated. The effect of the family-based DOTS support program is 
elaborated and discussed.   
 
Results 
  Part I: Subjects’ characteristics  
  Subjects’ characteristics refer to characteristics of patient, family, and 
DOTS supporter. Table 4 shows subjects’ characteristics in both experimental group 
as well as control group. Data of experimental group revealed that more than half of 
the subjects were married (53%) and Sundanese (87%). The average age of this group 
was 33.50 years (SD = 15.42) and gender was equally represented. The subjects of the 
control group were dominated by Sundanese (97%) and Muslims (100%) with 
average age of 34.17 years (SD = 14.12).  
In order to examine the significant differences of patient characteristics 
between the experimental group and the control group, t-test, Mann-Whitney U test, 
and chi square were applied. The findings revealed that all patient information 
between experimental and control groups did not show significant statistical 
difference. 
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Table 4 
Frequencies and Percentages of Patients’ Characteristics of the Experimental Group 
and the Control Group (N = 60) 
Patient 
Information 
Experimental Group 
(n = 30) 
Control Group 
(n = 30) Statistics p 
n % n % 
Gender       
Male 15 50.00 14 46.67 .00b 1.00 
Female 15 50.00 16 53.33   
Marital Status       
Single 13 43.33 11 36.67 1.17a .56 
Married 16 53.33 16 53.33   
Widowed/ 
Divorced 
1 3.33 3 10.00   
Ethnicity       
Sundanese 26 86.67 29 96.67 1.96c .35 
Javanese 4 13.33 1 3.33   
Occupation       
Occupied  12 40.00 16 53.33 .60b .44 
No occupied  18 60.00 14 46.67   
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = t-test, e = Mann 
Whitney U test 
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Table 4 (continued) 
Patient Information 
Experimental Group 
(n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
Education Level       
< Senior high school  17 56.67 16 53.33 .00b 1.00 
≥ Senior High School  13 43.33 14 46.67   
Income (per month)       
< minimum wage rate 16 53.33 18 60.00 .07b .79 
≥ Minimum wage rate  14 46.67 12 40.00   
Distance (Km)  Md = 2.50 Md = 2.00 -1.78e .08 
 IQR= 3.00 IQR= 2.00   
< 5 Km 27 90.00 29 96.67 1.07c .61 
≥ 5 Km 3 10.00 1 3.33   
Age (year) M = 33.50 M = 34.17 .18d .86 
 SD = 15.42 SD = 14.12   
15-29 year 16 53.33 15 50.00 .12a .94 
30-44 year 5 1.67 6 20.00   
≥ 45 year 9 30.00 9 30.00   
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = t-test, e = Mann 
Whitney U test, Md = median, IQR = Interval Quartile Range 
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Table 5 illustrates the comparison of health-related data between the 
two groups. The experimental group had 77% of smear positive pulmonary TB. The 
means of length of treatment, medications number and BMI were 18.80 days               
(SD =14.19), 3.00 tablets (SD = .53), and 18.70 (SD = 2.73), respectively. The control 
group was dominated by smear positive of pulmonary TB (80%). Length of treatment, 
medications numbers, and BMI had means 26.10 days (SD = 12.18), 2.93 tablets    
(SD = .58), and 18.30 (SD = 2.83), respectively.  
  Independent t-test was used to examine whether the experimental and 
the control groups had any differences in three characteristics, i.e., length of 
treatment, numbers of medications taken, and BMI that met with assumptions of t-
test. Mann-Whitney U test was employed to data that violated assumptions of t-test 
(i.e., duration of exercise). The results showed that both number of medications taken 
and BMI were not significant in statistical difference between the two groups. 
However, length of treatment for the experimental group was shorter (M = 18.80 days, 
SD = 14.19) than the control group (M = 26.10 days, SD = 12.18) (t = 2.14, p < .05). 
In addition, chi square was applied for the rest of health-related information and the 
results indicated no significant statistical difference between two groups. 
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Table 5 
Frequencies and Percentages of Health-Related Characteristics of the Experimental 
Group and the Control Group (N = 60) 
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = t-test 
 
 
Health-Related 
Characteristics 
Experimental 
Group (n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
Type of TB       
Smear negative 7 23.33 6 20.00 3.28 a .51 
Smear positive 23 76.67 24 80.00   
Health Insurance       
Yes 10 33.33 4 13.33 2.33b .13 
No  20 66.67 26 86.67   
Routine activity       
Yes 19 63.33 26 86.67 3.20b .07 
No 11 36.67 4 13.33   
Exercise        
Yes 11 36.67 12 40.00 .00b 1.00 
No 19 63.33 18 60.00   
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Table 5 (continued) 
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = t-test 
 
Health-Related 
Characteristics 
Experimental 
Group (n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
Exercise Duration 
(minute/ week) 
      
0-30 minutes 27 90.00 27 90.00 .00a 1.00 
30-60 minutes 2 6.67 2 6.67   
60-90 minutes 0 0.00 0 0.00   
90-120 minutes 1 3.33 1 3.33   
Smoking 1 3.33 3 10.00 1.25a .54 
Current 9 30.00 7 23.33   
Ex-user 20 6.67 20 66.67   
Never 0 0.00 0 0.00   
Drinking alcohol       
Ex-user 6 20.00 1 3.00 4.44c .10 
Never  24 80.00 29 97.00   
Consuming Drugs       
Ex-user 1 3.00 0 0.00 1.02c 1.00 
Never  29 97.00 30 100.00   
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Table 5 (continued) 
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = t-test 
 
Symptoms of each group are provided in Table 6. Every patient may 
have had more than one symptom. The most common symptoms experienced by the 
subjects in the experimental group were cough (77%), nigh sweat (50%), and fatigue 
(33%). Whilst in the control group, night sweat, itching, and headache were the most 
common symptoms complained by the subjects. There was no significant statistical 
difference of the symptoms between the groups. However, the p value of joint pain (p 
= .05) was close to the cut point of the significant difference between two groups.  
 
 
 
 
 
 
Health-Related 
Characteristics 
Experimental 
Group (n = 30) 
Control Group  
(n = 30) Statistics p 
M SD M SD 
Length of treatment 
(day) 
18.80 14.19 26.10 12.18 2.14d .04 
Number of  Medications 3.00 .53 2.93 .58 -4.65d .64 
BMI 18.70 2.73 18.30 2.83 -.56d .58 
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Table 6 
Frequencies and Percentages of Symptoms of the Experimental Group and the 
Control Group (N = 60) 
Symptoms 
Experimental 
Group (n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
Fever 6 20.00 7 23.33 .00a 1.00 
Cough  23 76.67 19 63.33 .71a .40 
Night sweat 15 50.00 10 33.33 1.10a .30 
Fatigue 10 33.33 6 20.00 .77a .38 
Nausea 9 30.00 7 23.33 .09a .77 
Vomiting  2 6.67 1 3.33 .35b 1.00 
Itching  8 26.67 10 33.33 .08a .79 
Headache 9 30.00 10 33.33 .00a .1.00 
Burn 
sensation 
1 3.33 4 13.33 1.96b .35 
Joint Pain  9 30.00 2 6.67 4.00a .05 
 a = Continuity Correction, b = Fisher’s exact test 
   
Family information is presented in Table 7, which reveals that most 
family had no chronic diseases in the experimental group (93%). More than half of 
the subjects in the control group had no TB (53%) or chronic disease (77%). Mann 
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Whitney U test and chi square were used to test difference in family characteristics 
between two groups. All family characteristics between two groups showed no 
significant statistical difference. 
 
Table 7 
Frequencies and Percentages of Family Characteristics of the Experimental Group 
and the Control Group (N = 60) 
Family Characteristics 
Experimental Group 
(n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
History of caring of TB       
Yes 15 50.00 14 46.67 .00b 1.00 
No 15 50.00 16 53.33   
History of caring of Chronic 
Disease 
      
Yes  7 23.33 7 23.33 .00b 1.00 
No 23 76.67 23 76.67   
FM with chronic disease       
Yes 2 6.67 5 16.67 1.46c .42 
No 28 93.33 25 83.33   
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = Mann Whitney U test 
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Table 7 (continued) 
Family Characteristics 
Experimental Group 
(n = 30) 
Control Group 
(n = 30) Statistics p 
n % n % 
Family Type       
Nuclear 17 56.67 13 43.33 .60c .44 
Non-Nuclear 13 43.33 17 65.67   
Family Size Md = 5.00  
IQR = 2.25 
Md = 5.00 
IQR = 2.00 
-.02d .98 
2-4 persons 12 40.00 10 33.33 .30a .86 
4-8 persons  16 53.33 18 60.00   
> 9 persons  2 6.67 2 6.67   
Vulnerable people       
< five years 16 53.00 14 47.00 .07b .80 
Elderly 7 23.00 6 20.00 .00b 1.00 
Pregnant women 1 3.00 1 3.33 .00c 1.00 
a = Chi square, b = Continuity correction, c = Fisher’s exact test, d = Mann Whitney U 
test, Md = median, IQR = interval Quartile Range, FM = family member  
 
Since matching technique was used for age (±5 years) and gender of 
DOTS supporters, both characteristics were equal in the experimental and the control 
groups. All DOTS supporters were Muslims. In order to examine DOTS supporters’ 
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characteristics, both chi-square and t-test were applied and no significant statistical 
difference between the two groups were found (Table 8).  
 
Table 8 
Frequencies and Percentages of DOT Supporters’ Characteristics of the 
Experimental Group and the Control Group (N = 60) 
a = Chi square, b = Continuity correction, c = t- test 
 
 
DOTS Supporters 
Characteristics 
Experimental Group 
 (n = 30) 
Control Group  
(n = 30) Statistics p 
n % n % 
Marital Status       
Single 2 6.67 3 1.00 .00a 1.00 
Married  24   80.00 26 86.67   
Widowed 4 13.33 1 3.33   
Occupation       
Employed 15 50.00 16 53.33 .00b 1.00 
Unemployed 15 50.00 14 46.67   
Education Level       
> Senior high school 24 80.00 24 80.00 .00b 1.00 
≥ Senior high school 6 20.00 6 20.00   
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Table 8 (continued) 
a = Chi square, b = Continuity correction, c = t- test 
 
Part II: Adherence to health behaviors  
The mean pretest score of adherence to health behaviors among the 
subjects participating in this study was 87.80 (SD = 9.06) for the experimental group 
and 89.73 (SD = 10.99) for the control group (Table 9). The total adherence to health 
behaviors was at a moderate level in both groups. The highest score was the sub-scale 
complying with anti-TB medications in each group. Performing physical activity sub-
scale was the lowest score in both groups and was at a moderate level. The rest of 
sub-scales were at a high level in every group though with an exception of the sub-
scale of preventing disease transmission in the experimental group and the sub-scale 
DOTS Supporters 
Characteristics 
Experimental Group 
(n = 30) 
Control Group  
(n = 30) 
Statistic
s 
P 
n % n % 
Relationship       
Father/ mother 12 40.00 13 43.33 3.53a .32 
Brother/ sister 2 6.67 4 13.33   
Spouse 12 40.00 6 20.00   
Son/ daughter 4 13.33 7 23.33   
Age (year) M = 39.97 
SD = 11.15 
M = 40.47 
SD = 12.43 
.16c .87 
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of maintaining environmental hygiene in the control group which were at a moderate 
level.
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Table 9 
Pretest, Means Score, and Standard Deviations of Adherence to Health Behaviors in the Experimental Group and the Control Group  
(N = 60) 
Pretest 
Experimental Group (n = 30)  Control Group (n = 30)  
M SD Min-Max Level M SD Min-Max Level 
Complying with anti-TB medications 17.47 2.06 13-20 High 18.70 1.49 16-20 High 
Following healthy diet 16.97 2.99 12-22 High 16.33 3.01 12-24 High  
Performing physical exercise 9.20 2.75 5-17 Low 10.33 3.43 5-20 Low 
Maintaining environmental hygiene 13.63 2.98 9-20 High 13.17 3.87 5-20 Moderate 
Preventing disease transmission 10.63 2.68 6-16 Moderate 12.47 3.18 5-16 High 
Avoiding risk factors 19.90 2.01 14-24 High 18.43 3.14 12-23 High 
Total scores 87.80 9.06 64-108 Moderate 89.73 10.99 67-110 Moderate 
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Part III: Effect of the family-based DOTS support program 
Hypothesis 1. The hypothesis 1 states that the total score of adherence 
to health behaviors of patients with pulmonary TB after participating in the family-
based DOTS support program is higher than the score measured before the 
intervention. The assumption testing showed that adherence to health behaviors scores 
at the pretest and the post-test are of normal distribution. The paired t-test revealed 
that the mean score of adherence to health behaviors after participating in the family-
based DOTS support program was significantly higher than the score before the 
participation (t = -10.34, p < .001). This result completely supported the hypothesis 1. 
Comparison of pretest and post-test scores of the control group is presented in Table 
10. There was no significant statistical difference between the pretest score and the 
post-test score of the control group. 
 
Table 10 
Total Scores and Standard Deviations of the Adherence to Health Behaviors within 
the Experimental Group and the Control Group (N = 60) 
Group 
Pretest Score  Posttest Score 
t p 
M SD M SD 
Experimental Group (n= 30) 87.80 9.06 109.23 13.18 -10.34 .00 
Control Group (n= 30) 89.73 10.99 90.60 8.82 -.34 .73 
 
  Hypothesis 2. Hypothesis 2 states that the total score of health 
behaviors adherence of patients with pulmonary TB who receive care from the 
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family-based DOTS support program is higher than the score of those who receive the 
routine care. Testing assumption showed that the datasets of adherence to health 
behaviors in subjects from the experimental group and the control group are normal 
distribution In order to examine the second hypothesis, baseline health behaviors 
adherence was assessed to detect any baseline difference of total scores using 
independent t-test. The result showed that there was no significant statistical 
difference in the baseline data of the total pretest scores between the experimental 
group and the control group (Table 11). It revealed that the total score of the 
experimental group (M = 109.23, SD = 13.18) was significant higher than the control 
group (M = 90.60, SD = 8.82) (t = -6.43, p < .001). 
 
Table 11 
Pre-Test, Means Scores, and Standard Deviations of the Adherence to Health 
Behaviors Between the Control Group and the Experimental Group (N = 60) 
Adherence to health 
behaviors  
Experimental group Control Group 
t-test p 
Mean SD Mean SD 
Pretest  87.80 9.06 89.73 10.99 .74 .46 
Post-test  109.23 13.18 90.60 8.82 -6.431 .00 
1= equal variance was not assumed (df = 50.63) 
 
ANCOVA was performed to determine the mean difference of 
adherence to health behaviors between the experimental group and the control group. 
The independent variable included the experimental group and the control group. The 
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dependent variable was the post-test of adherence to health behaviors and the 
covariates were the length of treatment and joint pain. Before conducting the 
ANCOVA, the homogeneity of regression was tested, during which time the 
interaction between the covariates and the factor (independent variable) in the 
prediction of dependent variable was assessed. The result showed that the interaction 
was not significant (F = .56, p = .46). Based on this finding, ACOVA proceeded. The 
underlying assumption of homogeneity variance for the ANCOVA was met, 
evidenced by F = 2.97, p = .09. The ANCOVA was thus significant. Table 12 
presents the total score of adherence to health behaviors on the fifth week of post-
intervention period, between the two groups. There was a significant statistical 
difference (F = 47.71, p ≤ .001) using the length of treatment and joint pain as the 
covariates. Therefore, the result fully supports the hypothesis 2. 
 
Table 12 
Comparison of the Experimental and the Control Groups’ Post-Test Regarding the 
Patients’ Adherence to Health Behaviors after Controlling Length of Treatment and 
Joint Pain (N = 60) 
Source Sum of 
Squares 
df Mean 
Squares 
F p Partial eta 
squared 
Between groups 5,341.37 1 5,341.37 47.71 .00 .46 
Length of Treatment  74.09 1 74.09 .66 .42 .01 
Joint Pain 944.04 1 944.04 8.43 .01 .13 
Error 6,269.75 56 111.96    
Total 611,507.00 60     
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  Additionally, the subjects in the experimental group made report every 
day of the program implementation. The report consisted of six health behaviors 
performed every day. Percentage of the number of health behaviors performed by 
patients each day was calculated. The subjects implemented the program for four 
weeks. The average percentage was calculated based on percentage of health 
behaviors from day 1 to day 7 in each week.  Percentage of each week of all health 
behaviors is illustrated in Figure 3. The highest percentage of implementation was at 
the third follow up, whilst the lowest percentage was at the first follow up. The 
percentage of implementation program increased every week except the last week. 
 
 
Figure 3. The percentage of health behaviors being performed across four-time 
follow- up  
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Discussion 
  Discussion of the study results consists of subjects’ characteristics (i.e., 
patient information, family information, and DOTS supporters), adherence to health 
behaviors, and the effect of family-based DOTS support program.  
 
Part 1: Subjects’ characteristics 
Subjects’ characteristics cover patient information, family information, 
and DOT supporters. 
Patient information. There were no significant difference in patient 
information between the experimental group and the control group. The gender of 
experimental group was equal, while the number of males in the control group was 
slightly higher than the female counterparts. These results were in contrary with the 
previous studies that found male gender as a risk factor of Tuberculosis (Lienhardt et 
al., 2005; Raj et al., 2012). The study of Usmani, Al-Khajah, Singh, Hussein, and 
Nurulain (2011) has stated that gender has no bearing on the prevalence of TB. TB is 
prevalent among men because of they tend to have more social contacts with greater 
risk of exposure to contagious disease. Moreover, different immunology between men 
and women contributes to the factor as well.   
Age is one risk factor of TB. The age averages were 33.50 years and 
34.17 years in the experimental group and the control group, respectively. Age group 
TB is most prevalent among the productive age (15-49 years), specifically in the age 
group of 25-34 year old. Atul et al (as cited in Bello & Itiola, 2010) have found that 
most of Tuberculosis cases occur in the productive age group of 15 - 49 years. This is 
in contrary to what has been found in the United States of America, where higher risk 
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of Tuberculosis is among the elderly (above 62 years) and less among those below 50 
years of age (Cantwell et al. as cited in Bello & Itiola, 2010). 
Most subjects in both groups were married. This result is different 
from the previous study, which revealed that the risk of TB was higher among the 
singles than the married (Lienhardt et al., 2005). This present study involved all 
Muslim subjects, most of whom were Sundanese. The study of Liedhardt et al (2005) 
revealed that there was no association between TB incidence and religion.  
Present study showed that unemployed subjects in experimental group 
were at a slightly higher risk than the employed subjects. This result was different in 
the control group. Previous study has revealed that unemployment is one of the 
significant characters among TB patients (Hoshino, Ohmori, Uchimura, & Yamauchi, 
2007). This study was conducted in Bandung, which is the third largest city in 
Indonesia. In  Bandung, the regional minimum wage rate in 2011 was IDR 1,188,435 
(USD 131.39). It was observed in both groups that the number of subjects who had 
income below the minimum wage was slightly higher than those who had income 
above the minimum wage. Therefore, income had pivotal role in developing TB. TB 
incidence is more likely to be higher among people with low income. Income has 
been reported as a significant predictor to adherence to health behaviors (Woith & 
Larson, 2008). 
Income is likely to in line with education level. Low income could be 
caused by low education level. Subjects of both groups had finished junior high 
school and below which paralleled with the income level in both groups. Despite the 
free TB services, most subjects in both groups lacked health insurance. Out of those 
subjects, most lived short distance from the assigned community health center. The 
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accessibility to health center was required among TB patients. Health insurance and 
the distance between home and community health centers influenced the patients’ 
adherence. 
Health-related information is included in patient information. There 
was no significant difference in the health-related data between the two groups, 
except length of treatment and joint pain. The length of treatment of experimental 
group was shorter than the control group. Most subjects in both groups had positive 
smear sputum. This finding is consistent with the study by Rao (2009), who has found 
higher ratio of smear positive than smear negative among TB patients.  
BMI could be used to represent nutrition status. BMI of both groups 
revealed no significant difference, with average at 18.70 in the experimental group 
and 18.30 in the control group. The normal range of BMI is 18.5-24.9. The mean BMI 
in the experimental group indicated normal weight. And in the control group indicated 
mild underweight. However, there was no significant difference of BMI between 
these two groups. BMI is a protective factor of TB (Hanrahan et al., 2010). Number of 
medications depends on body weight – the means of medications for the experimental 
group and the control group were 3 and 2.93, respectively. Previous study has found 
that number of medications is the barrier in implementing adherence to medication 
(Munro et al., 2007).  
Cough, night sweat, and fever are the common symptoms of TB and 
they happened in particular subjects. More than half of the subjects still had cough 
which was similar with the study of Bello and Itiola (2010). Nonetheless, only few of 
them still had fever and headache which is similar to the description of Chan, Woo, 
Or, Chan and Cheung (1995).  
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Regarding the side effects, none of the subject reported major side 
effects (i.e., jaundice). Fatigue, nausea, and itching were common in this present 
study. This finding is similar to the study of Koju, Rao, Shrestha, Shakaya, and 
Makaju (2005). Pyrazinamide may be responsible for joint pain while itching might 
occur because of Pyrazinamide, Rifampicin and Isoniazid, and Pyrazinamide and 
Rifampicin are the possible causes of nausea, vomiting, and anorexia (WHO, 2009b).   
Regarding risk behaviors, most subjects never smoked, drank alcohol, 
and used drugs. However, smoking is consistently found to increase the risk of TB 
(Liendhardt, 2005). In addition, drinking alcohol and using drugs are more likely 
among TB patients (Fleming et al., 2010). Regarding their activities and exercises, 
most subjects in both groups had had no routine activity and exercise which could be 
because they were required to rest once they were diagnosed. 
  Family Information. Numbers of families who had had history of 
caring for TB were almost equal in both group, however most of the participating 
families had had no experience in caring chronic disease. The burden of family is 
limited due to most of family was no having chronic disease. Most subjects in the 
control group had a non-nuclear family but most from the experimental group had a 
nuclear family. Similar to most Asian countries, extended family also dominates in 
Indonesia. However, the nuclear family appears mostly in the big city and among 
young families. More than half of both groups had 4-8 persons in the household. 
Liendhardt (2005) has unveiled that the risk of TB is enhanced by the number of 
family member. 
There were few elderly and pregnant women in both groups. 
Meanwhile, children under five years of the experimental group were slightly higher 
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than the control group. Based on Zevallos and Justan (2003), the elderly are 
vulnerable to TB because of the weakening immune system. Children and pregnant 
women also are also vulnerable to TB due to low immune system.  
  DOTS Supporter. The DOTS supporters were dominated by females 
and marrieds in both groups. The study of Manders et al (2001) and Phromrak, 
Hatthakit, and Isaramalai (2008) yield similar gender composition among DOTS 
supporters to the current study. Based on cultural expectation, women are expected to 
perform care-giving task. The relationship with the patients was largely conquered by 
parent relationship and spouse relationship in both groups. The average age of 
supporters were 39.97 years in the experimental group and 40.47 years in the control 
groups. In contrast, most DOT supporters in Thailand are children (Phromrak, 
Hatthakit, & Isaramalai, 2008). This difference could be explained by the fact that the 
subjects of this present study were younger. Moreover, all DOT supporters were 
Muslim and most of them had education level below senior high school. The ratio of 
the employed and the unemployed was equal in both groups. Of all the DOT 
supporters’ characteristics, none showed significant differences between the two 
groups. 
 
  Adherence to health behaviors 
The baseline data of total adherence to health behaviors was at a 
moderate level in the experimental group and the control group. Based on the sub-
scales, complying with anti-TB medications had the highest score and performing 
physical activity had the lowest score.  
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The highest score in each group was complying with anti-TB 
medications. Taking medication was the most concern among the TB patients, 
evidened by the pretest scores that were in a high level for both groups. Additionally, 
DOTS officers in the community health center focused on this same aspect. 
Comparing with other health behaviors, medications taking behaviors were the most 
discussed topic with the patients. Moreover, TB patients only took the medications 
once a day regimen and the study of Eisen et al (1990), as cited in Martin, Williams, 
Haskard, & DiMatteo (2005), has revealed that once-daily medication has higher 
adherence compared to thrice-daily medication among hypertension patients. It seems 
that the health care providers only focus on medication adherence instead of the 
whole TB behaviors as indicated by most research (Martin, Grace, & Kelly, 2008; 
Trajman et al., 2010).  
The sub-scale of following health diet was at high level in every group. 
It was supported by the normal of the BMI average in each group. Out of all items of 
this sub-scale, “I drink a glass of fruit juice or eat some fruit” and “I eat vegetables at 
every meal” were the lowest score. The score of fruits and vegetables taking was low 
in the present study, which is in agreement with the previous finding (Duran, 
Almeida, & Segurado, 2008).    
Sub-variable of physical exercise was the lowest score in both groups. 
Because of particular symptoms (i.e., fatigue, joint pain), performing physical 
exercise was challenging to TB patients. The patients preferred to not conduct the 
exercise because of their weak condition. However, patients who performed physical 
activity felt healthier. The physical activity depends on patients’ condition and 
walking, breathing exercise or other mild exercises are more suitable for them. Out of 
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the six health behaviors during the fifth week, adherence to physical activity was 
considered to be the most challenging and adherence to medication had a higher 
score. Martin, Williams, Haskard, & DiMatteo (2005) have stated that exercise 
commonly creates significant difficulties for patients. These adherence descriptions 
are similar to the study of Roserahaini, Ayub, and Oduola (2011) in diabetic patients 
in Brunei Darussalam.  
The maintaining environmental hygiene sub-scale was at high level in 
the experimental group and moderate level in the control group. The items related to 
polluted environment and poor ventilation had low scores in the experimental group 
while the items related to overcrowding, ventilation, and polluted environment had 
low scores in the control group. The TB patients need appropriate living conditions 
such as reducing the crowdedness, reducing polluted air, and reducing dust 
(Department of Family and Community Services as cited in Bailie & Wayte, 2006). 
Schmidt (2008) has stated that crowding, poor ventilation, and smoke produced by 
cigarettes and stoves are the crucial threats to the environment for TB patients.  
The sub-scale of disease transmission had the moderate level in the 
experimental group as well as in the control group. The item “I dispose the tissues/ 
masker with sputum immediately into a covered container that contains antiseptic” 
was the lowest score. Antiseptic is rarely used because TB patients often have no idea 
the benefit of antiseptics.  
The sub-scale of avoiding risk factors was at moderate level in every 
group. Referring to the characteristics of subjects (Table 5), most of them had no 
smoking, drinking alcohol, and using drugs that were the risk factors of TB. Out of 
the items of this sub-scale (Appendix H), “I try to stay away from stressors” had the 
116 
 
lowest score. The stigma of TB is correlated with the stressors of TB patients. Shame, 
isolation, and fear are linked with TB (Juniarti & Evans, 2010).   
  
Effects of the family-based DOTS support program 
Hypothesis 1 and hypothesis 2. Hypothesis 1 states that the mean score 
of adherence to health behaviors of patients with pulmonary TB after receiving 
services from the family-based DOTS support program is higher than the score 
measured before the intervention. Result of hypothesis 1 confirmed there was no 
maturation of this study. Hypothesis 2 states that the total score of health behaviors 
adherence of patients with pulmonary TB who receive care from the family-based 
DOTS support program is higher than the score of those who receive the routine care. 
The result of this study confirmed the effect of the family based DOTS support 
program in enhancing adherence to health behaviors.  The subjects of the 
experimental group had significantly improved their adherence to health behaviors 
after participating in the family-based DOTS support program (Table 12).  After 
receiving care from the family-based DOTS support program, the total score of 
adherence to health behaviors in the experimental group was significantly higher than 
those in the control group.  
Family-based DOTS support program consisted of family as DOT 
supporter, supportive educative program, and operational capabilities based on 
SCDNT’s Orem (2001). Information sharing, participation, and collaboration are the 
main standards of application (Johnson et al., 2008, as cited in Abraham & Moretz, 
2012) and were integrated in this program. The patients and their families were 
prepared by enhancing their knowledge. The patient, family, and the researcher were 
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involved in planning, delivery, and evaluation of desired outcomes as well as any 
decision making and action planning. Abraham and Moretz (2012) have stated that 
application of these partnership and collaborations would provide mutual benefits to 
the patients and healthcare provider. 
The results of this study are consistent with the other studies that used 
supportive educative program in increasing self-care behaviors of TB patients 
(Ngamtrairai, 2003), COPD (Kamsee, 2004), diabetic patients (Mohhamed, 2005), 
pregnant women with premature labor pain (Wongtongchareon, 2003), and 
hypertension with chronic Hemodialysis (Kauric-Klein, 2011). Some previous 
studies, which applied supportive educative program by involving family caregiver, 
have revealed higher dependent care behaviors (Sirireung, 2005) and increase self-
care behaviors of children with asthma (Kiatthitinun, 2005). 
Adherence to health behaviors is important to achieve the successful 
TB treatment. The present study revealed the positive outcomes after conducting the 
program. Some reasons support the positive outcomes of this study were: 1) the 
program was driven by theoretical foundations; 2) family support and partnership; 3) 
active involvement; and 4) continuous follow up. 
Firstly, the effect of the family-based DOTS support program was 
largely contributed by using Orem’s self-care deficit nursing theory as a theoretical 
foundation. Self-ability, motivation, and supportive environment are required in order 
to integrate the adherence to health behaviors as part of self-care. 
Self-ability, motivation, and supportive environment are required in 
order to integrate the adherence to health behaviors as part of self-care. A gradual 
increase and development of adherence to health behaviors could be achieved through 
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four helping methods within three phases: estimative, transitive, and operative 
operations. Estimative phase was conducted by helping the TB patient and his/ her 
family gain an overview of TB and health-related behaviors. This phase is important 
to establish the appropriate actions (Orem, 2001). The second and third phases were 
applied within four days. During this phase, the patients had a chance to perform 
health behaviors as explained in the estimative phase. Transitive phase was arranged 
to assist the clients (patient and family) to make judgments and decisions about the 
care of TB patients especially regarding each health related behavior. The last was 
operative phase which was to promote patients and their families to make action 
plans. Since these plans were made by the patients, commitment of implementing 
health behaviors was elevated.  
The helping methods ensure that the patients were able to gain 
information and knowledge that would be helpful in implementing adherence to 
health behaviors. These helping methods were applied all through the program. 
Teaching method was applied in all phases, including TB overview and health 
behaviors of TB. The knowledge is positively correlated with adherence in TB 
patients (Kaona, Tubal, Siziya, & Sikaona, 2004; Munro et al., 2007). Considering the 
background of the patients, simple language and additional media such as flipchart 
and booklet were applied in this intervention. Patients and their families had 
opportunity to ask particular questions and requested further explanations that were 
essential in gaining better understanding. Additionally, written and spoken 
information including pictures were provided to facilitate teaching process. Houts, 
Doak, Doak, and Loscalzo (2006) has revealed that using both written and spoken 
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teaching materials enhance knowledge greater than using one of them especially when 
pictures are presented.  
Guiding method was conducted in transitive and operative phases. This 
program helped patient to increase the health literacy and therefore enhanced their 
informed decision by identifying the benefits and limitations of each behavior and 
promoting action plans. The appropriate guidance is valid while making choice and 
practicing a course of actions are performed (Orem, 2001). This method was in 
conjunction with supporting and providing environment methods. 
Supporting was conveyed by information and psychological supports. 
Through these supports, individual is able to make decision, think about the situation, 
and initiate an action (Orem, 2001). Providing response to every question and 
supportive communications (i.e., reinforcement, motivation, and appreciation) were 
significant in increasing patients’ assurance in applying health behaviors.  Providing 
environment was employed to ensure comfortable, trusting environment and gain 
trust. Patients and their families had opportunity to communicate with the researcher 
besides the scheduled time. In addition, respect and caring for the patients and their 
families were provided.  
Secondly, family support has been proved to encourage health 
behaviors. The patient’s support system contributes to his/her well-being and positive 
outcomes. Family support is one of the basic conditioning factors that adjust 
individual’s ability (Orem, 2001). In fact, there is a consistent body of evidence 
regarding positive relationship between family support and health behaviors (Biswas, 
2010; Nasution, 2007). Family actively participated in every session of intervention 
that helped achieve and maintain patients’ health behaviors. Therefore, the family also 
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gained knowledge and information in caring for TB patients regardless of low 
education level of DOTS supporter. Based on the review of Bevan and Pecchioni 
(2008), family with low literacy needed written information and close relationship 
that were provided in this current study.  
In Indonesia, family intimacy and cohesiveness tie family in Indonesia. 
This values motivated family members to maintain and help improve their patient’s 
health in the study. Since DOT supporters were chosen by the patients, they were 
considered the closest family members (i.e., parents, children, and spouse). Parents as 
DOTS supporters were believed to be the most authoritative persons in the family as 
they were greatly appreciated and supported by the family member. Like most Asian 
cultures, children in Indonesia must help their parents especially while encountering 
health problems. Spouses as DOTS supporters created and facilitated the commitment 
to support and help the patients in achieving adherence to health behaviors. This is 
consistent with the study of Gillibrand and Stevenson (2007), which has revealed that 
there is an association between social support and adherence reported by the patients 
and their spouses. 
Thirdly, the involvement of the Tuberculosis patient in every activity 
of intervention made the patients more likely to perform better health behaviors. 
Patients had opportunity to ask questions and shared their thoughts in every phase. 
This helped the patients build more commitment and confidence to perform health 
behaviors. Moreover, the program allowed patients to freely express concerns 
regarding any barriers that could potentially stop the action plan during the 
implementation of intervention. Previous studies have revealed that active 
participation produces better outcomes of health behaviors. Additionally, 
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communication between the researcher and the clients strengthened the 
implementation of this program. Various communication strategies were applied in 
this intervention. Open-ended questions, patient-centered active listening, and 
directive statements are the best way to enhance concerns about the disease and 
reduce concern about the medications. Shared decision making was engaged and this 
strategy could address the barriers (Hahn, 2009). In addition, continuous interaction 
between researcher and the clients have an effect on the patients’ psychological state. 
Jakubowiak et al (2008) has stated that improving adherence can be achieved by 
facilitating psychological communication and providing social support and health 
education.  
Lastly, this present study included two telephone follow up and a face-
to face follow up. Previous studies have proved that continuous follow up maintains 
health behaviors of TB. Those follow ups were essential to evaluate implementation 
of the program as well as to help patient overcome the barriers. Telephone 
interventions to produce behavioral changes confirmed positive outcomes. However, 
more favorable outcome are confirmed when including face-to-face follow-up 
sessions and print materials (Eakin, Lawler, Vandelanotte, & Owen, 2007; Chung & 
Hwang, 2008).  
However, the combination of those aspects strengthened the favorable 
outcome of this study. In order to change patient’s adherence, strategies were used not 
only by involving patient into decision-making process and teaching particular 
information and skills but also using effective teaching methods and strategies (Viña, 
2005). A follow up is needed to enhance long-term improvement of adherence by 
providing reinforcement information, monitoring, and ongoing skill training. 
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Education is an essential resource to address all barriers of adherence. Strengthening 
and maintaining a collaborative patient-provider relationship could enhance patient’s 
adherence because of satisfying relationship (Rubin, 2005).   
  Despite the significant difference of base line data of certain health-
related variables (i.e., length of treatment and joint pain) between the two groups, the 
effect of the family-based DOTS support program was established after adjusting the 
covariates. In spite of the effect of this program, the implementation of health 
behaviors was not consistent in every follow up. The third follow up showed the 
highest percentage of heath behaviors adherence implementation while the first of 
follow up showed the lowest percentage. The first follow up was not at the peak of 
implementation since the whole intervention had just been completed. Therefore, the 
patients and their families needed more time to adjust the health behaviors adherence. 
Benefits of the intervention and encouragements provided during the telephone follow 
up may have contributed to the climax of implementation at the third follow up. 
However, the last follow up had unwanted reduction of percentage of implementation. 
In order to maintain the consistency of implementation of the program, final 
reinforcements were provided to the patients and their families. Therefore, 
termination of intervention was essential to establish permanent adherence to health 
behaviors. 
  The control group did not receive the same intervention and had steady 
health behaviors adherence score. The usual program, whose service that was 
provided by health providers, was routine activities. During each visit, the patients 
were given the medications and asked about any side effects. There was no 
information about health behaviors given, apart from the health education that was 
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often conducted in the first treatment. Most health providers were concerned about 
medication and so explained the considerably high score of complying with anti-TB 
medications sub-variable. Moreover, considering the limitations of patients and their 
families’ characteristics, the ability to gain knowledge and skills by themselves was 
inadequate. More than half of them had low education level and economic status. 
Education has been proven to be helpful in practicing self-care (Orem, 2001). 
  Comparing with the previous study of family DOTS supporter for TB 
patients, this current study had approached health behaviors wholly instead of 
focusing only on the medications or treatment outcomes. In addition, the effect size of 
this study was 1.18 and was considered large per Cohen’s effect size. This recent 
study produced practical knowledge in enhancing adherence to health behaviors for 
TB patients. The family-based DOTS support program was able to enhance health 
behaviors in pulmonary TB patients. The TB booklet contributed to accomplishing the 
desired outcomes.  
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CHAPTER 5 
CONCLUSION AND RECOMMENDATIONS 
 
  The conclusion of this study composes of summary of the study based 
on the research findings, the strength and limitations of the study, as well as 
implications and recommendations. 
 
Conclusion 
This cluster randomized trial with a two-group – pre-test and post-test 
– design aimed to test the effect of the family-based DOTS support program on 
adherence to health behaviors. Sixty subjects participating in this study were recruited 
from ten community health centers in Bandung, Indonesia. The inclusion criteria of 
the subjects were: 1) older than 15 years of age; 2) had confirmed diagnosis of 
pulmonary Tuberculosis and was at the intensive phase of TB treatment; 3) a new 
case of Tuberculosis treatment; 4) had no diagnosis of MDR-TB; 5) had no 
underlying diseases with long-term treatment, namely, diabetes, hypertension, chronic 
renal failure, and others; 6) had no diagnosis of HIV/ AIDS; and 7) able to write and 
read the Indonesian language.  
This study was conducted over a four-month period. The subjects in 
the control group received regular care for five weeks and the subjects in the 
experimental group received care through the family-based DOTS support program 
for five weeks. This program consisted of estimative, transitive, and operative 
operations, including four helping methods – teaching, guiding, supporting, and 
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providing environment. In addition, two telephone follow-ups and one face-to-face 
meeting were conducted in this study. Booklets were provided in order to help 
patients and their families learn about TB. Adherence to health behaviors 
questionnaire, which had .78 of Cronbach alpha and had also been evaluated by three 
experts, was used to measure the subjects' pretest and post-test scores of their 
adherence to health behaviors.  
Both descriptive and inferential statistics were used in this current 
study. The results revealed that there were no significant differences in the subjects' 
characteristics, except the length of treatment and joint pain symptom. Total score of 
adherence to health behaviors in the experimental group was significantly higher after 
receiving care from the family-based DOTS support program than the total score 
before participating in the program. There was, however, no significant improvement 
of adherence to health behaviors among subjects in the control group. In addition, 
total score of adherence to health behaviors of experimental group was significantly 
higher than the control group on the fifth week. ANCOVA was applied to adjust two 
covariates (i.e., length of treatment and joint pain). The adjustments helped confirm 
the success of the program in enhancing adherence to health behaviors in the control 
group. 
 
Strengths and Limitations of the Study 
In order to test the intervention, two groups of the pretest and the post-
test were the most appropriate design. Cluster randomization was applied in this study 
to eliminate selection bias. Matching technique for DOT supporter characteristics (age 
and gender) was applied to ensure that neither age nor gender would influence the 
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support provided by the DOT supporters. This program was driven by the theoretical 
foundations based on Orem's SCDNT, which consisted of estimative, transitive, and 
operative phases, including four helping methods. Booklets were distributed to help 
the subjects and their families gain knowledge about TB overview and health 
behaviors. Two types of follow-up were conducted, specifically two telephone follow-
ups and a face-to-face follow-up. 
Despite the strength of this study, there are some limitations that 
should be included in the interpretation of the results. This study used ten community 
health centers but no equal number of subjects in each location. Therefore, cluster 
analysis could not be performed. There was no blinding technique applied in this 
study as it could incur bias.  
 
Implications and Recommendations 
  The implications refer to implications for nursing research and nursing 
practices 
  Implications for nursing research 
 In spite of its limitations, this study provides evidence that the family-
based DOTS support program may be essential to enhance adherence to health 
behaviors. Presently, no study in Indonesia has tested how a family-based DOTS 
support program may increase health behaviors adherence. Since the score of 
performing physical activity sub-scale was at a low level, the patients thus needed to 
be reminded to follow this health behavior. In addition, each community health center 
involved the health volunteers in the implementation of TB control. Therefore, some 
implications that should be encouraged are as follow: 1) there should be a continuity 
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of care system to examine the consistency of adherence to health behaviors; 2) TB 
study could involve the health volunteers and the community to improve adherence to 
health behaviors and maximize TB control and management; and 3) this program may 
be used on other populations (i.e. HIV/ AIDS or other chronic diseases) though 
adjustment of materials and testing of the program’s effect would be needed for 
further research.  
  
Implications for nursing practice 
The results of this study indicate that the family-based DOTS support 
program could enhance adherence to health behaviors. The program contains clear 
intervention guidelines and methods to be applied by nurses to promote adherence to 
health behaviors. The patients and their families should be involved in the decision 
making and planning of Tuberculosis care. In addition, this study provides TB 
booklets that could be helpful for the patients and their families to adhere to health 
behaviors. The follow-up method is required to ensure the adherence to health 
behaviors of the patients. However, the duration and frequency of the follow-up need 
to be adjusted to fit the capacity and condition of the selected community health 
centers. This program may be considered by health policymakers and nursing system 
in increasing the quality of care and accelerating TB control and management.  
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Appendix A 
General Information of Reviewed Studies of Family Member as DOT Supporter 
 
Author Country Study 
Design 
Sample 
size 
Age Type of 
TB 
TB 
Hist
ory 
Includin
g HIV/ 
AIDS 
Outcomes Results 
Anuwatnontha
kate et al. 
(2008) 
Thailand Cohort: 
HCP vs. FM 
vs. SA 
8,312 
(4% vs. 
59% vs. 
18%) 
All 
ages 
Pulmonary No Yes Success 
rate 
All meet WHO target except SA 
HCP>FM>SA 
…  … … … … … … … … 
          
Wright et al. 
(2004) 
Swaziland 
(Africa)   
RCT: FM 
vs. HCP 
1353 
(667 vs. 
668) 
All 
ages 
Pulmonary 
and extra 
pulmonary 
Yes N/A Success 
rate 
There was not significant of 
compliance rate between FM DOT 
and HCP groups; Both don’t meet 
with WHO targets (HCP [72%]> 
FM[66%]) 
Note. HCP= health care provider, FM= family member, SA= self administered, N/A= not available 
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Appendix B 
General Information of Reviewed Studies of Supportive Educative Program 
 
Author Country Study 
Design 
Population Sample 
size 
Outcomes Results intervention 
Wonghong
kul, et al 
(2008) 
Thailand Quasi 
experi
mental 
2 
groups 
Breast 
cancer 
survivor 
61 
(CG=31, 
IG= 30) 
Quality of life 
(T1= before, 
T2= after 
program and 
T3= after 3 
months) 
1. There were a significance 
differences in quality of life mean 
score between groups (F =5.313, 
p= .025) and within groups (F 
=6.682, p= .002) were shown. 
2. The mean score is not higher in 
experimental group and there was 
no significant different 
4-hour sessions, 
conducted 4 times 
continuously with 2 
weeks interval 
… … … … … … … … 
Mohamed 
(2005) 
Malaysia Quasi 
experi
mental 
Diabetes 60 Self-care 
practices 
The self-care practices of patients in 
experimental group were 
significantly higher than the control 
group in all domains (dietary control, 
exercise, medication taking, stress 
The five provisions of 
helping methods 
(teaching, guiding, 
supporting, provide an 
healthy environment) 
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Author Country Study 
Design 
Population Sample 
size 
Outcomes Results intervention 
management, & personal hygiene) and handbook about 
dietary control, 
exercise, medication 
taking, stress 
management, & 
personal hygiene 
Note. IG= intervention group, and CG= control group  
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Appendix C 
Effect Size Calculation 
 
1. Effect Size of the Previous Study 
The calculation effect size (d) of this study is as follows: 
d = M1-M2/SD pooled and where SD pooled= √ [(SD12+SD22)/2] 
Where M1= mean of experimental group 
 M2= mean of control group 
 SDpooled= standard deviation of the control group and experimental group 
SDpooled = √(21.25)2 + (37.83)2/2 
 = √(451.56 + 143.11)/2 
 = √941.34 = 30. 68  
d = M1-M2/SD pooled = 59.16/30.68 = 1.92 
 
2. Effect Size of the Current Study 
Pooled SD = (13.18)2 + (8.82)2 
 = (173.71) + (77.79) = 251.5 
 = 15.86 
ES = 109.23 – 90.60  =  18.63 
  15.85       15.85 
 = 1.18 
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Appendix D 
Research Information Sheet 
 
Informed Consent 
 My name is Desy Indra Yani, I am a master student at Faculty of Nursing, 
Prince of Songkla University, Thailand. I am also a lecturer of Faculty of Nursing, 
Padjadjaran University, Indonesia. I am conducting a research entitle “Effect of 
Family-Based DOTS Support Program on Adherence to Health Behaviors in Patients 
with Pulmonary Tuberculosis in Indonesia”. This study will be held for five weeks 
and the findings of this study are expected to improve the quality health care of 
patients with pulmonary tuberculosis. This study has been approved by the 
Institutional Review Board (IRB) of Prince of Songkla University, Thailand and also 
has been granted permission from Bandung Local Government and Health 
Department Bandung District, Indonesia. You are asked to participate in this study. If 
you are interested, I will begin the procedures as follows: 
Explanation Procedures 
1. You will be assigned to either the experimental group or the control group. 
2. If you are in the experimental group, you will be given family-based DOTS 
support program during the period of study.  
3. If you are in the control group, you will not be given this program. You will 
continue receiving regular treatment. However, if you want to receive the similar 
program, you will be given after the end of the study period.   
Evaluation and Forms 
1. You will be asked to fill the forms about your personal data and general health 
information. This will take time around 15 minutes.  
2. You also will be asked to fill adherence to health behaviors questionnaire in the 
first week and the fifth week of the intervention. This activity will take time 
another 15 minutes. 
Risk and Comfort 
There is no known risk or harm for participating in this study. However, this 
program may make you spend more time with us. Furthermore, there is neither cost 
nor payment to you for your participation in this study. 
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Benefits 
 The finding of this study will be beneficial specifically having a protocol to 
the nurses and other healthcare providers in order to provide the better quality of 
tuberculosis management through family-based DOTS support program by improving 
patient’s adherence to health behaviors. Thus, the improvement of adherence to health 
behaviors will promote your overall quality of life. In addition, it will be useful for the 
future research related to this topic. 
Confidentiality 
 All information and your responses in this study will be kept confidential and 
anonymous. Moreover, only the researcher and research advisors will access the data. 
The report of this study will not use your name or any identifying information. 
Participation and Withdrawal from Participation 
 Your participation in this project is voluntary. You will be given 30 minutes to 
think before deciding to participate or refuse from this study. Returning the forms 
given indicate that you understand what is involved and you consent to participate in 
this study. You also have right to withdraw from participation in this study at any time 
without any consequences or penalty. In addition, there is no influence on receiving 
service and any medical treatment if you decide to withdraw from this study. 
Finally, if you have any questions or suggestions, you can directly contact me 
by phone +628122075874. If you agree to participate in this study, please kindly sign 
your name on the consent form. 
Thank you very much for your kind cooperation. 
 
Desy Indra Yani 
 
Researcher  
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Research Information Sheet  
Family-Based DOTS Support Program Group 
 
During this program you will receive following procedures: 
1. The first week of intervention 
a. Initially, you will be asked to fill some forms including the demographic data 
and adherence to health behaviors questionnaire. Totally this activity will take 
time around 15 minutes. In this step, the research assistant will help you to 
complete the forms. 
b. You will join in three sessions’ knowing operation, decision-making 
operation, and actions-plan operations. The discussion will be done in every 
session to help the patient in increasing adherence to health behaviors. 
c. You will receive the tuberculosis care booklet to facilitate your further 
learning and will be asked regarding the time for follow-up phone call that you 
available for.  
2. The second and third week of intervention 
In these periods, the researcher will make two follow-up phone calls to evaluate 
your current progress in implementing this program. During this activity, you will 
be asked to report your progress regarding your adherence to health behaviors 
being implemented and revise or continue the plan. In this session you will also be 
allowed to share any difficulties during implementation or ask questions or 
suggestions from the researcher to improve adherence to tuberculosis treatment. In 
addition, the researcher will guide in order to assist you maintain and improve 
adherence to health behaviors.  
3. The fourth week of intervention. 
In the last week of the study, you will be followed up by the researcher at your 
home in order to review your weekly adherence to health behaviors improvement 
progress. You and the researcher collaboratively review your daily and weekly 
health behaviors that you implemented each week. Similar with follow up phone 
call, in this session you are allowed sharing your difficulties that you face during 
implementing this program and discussing the possible solutions with the 
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researcher. In addition, if necessary the researcher will guide in order to assist you 
solving the difficulties. The process will take time approximately 20 minutes 
depending on your needs 
4. The fifth week of intervention 
At the end of the program, you will be asked to fill the adherence to tuberculosis 
treatment questionnaire. This will take time around 15 minutes. The research 
assistant will help you to complete the form. 
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Inform Consent Form 
 
Title :  Effect of Family-Based DOTS Support Program on Adherence to 
health behaviors in Patients with Pulmonary Tuberculosis in Indonesia 
Researcher : Desy Indra Yani (Master Student at Faculty of Nursing, Prince of 
Songkla University, Hatyai, Thailand) 
 
Patient’s Name: ………………………………………Age:…………………… 
Patient’s Consent 
 I,……………………………, was informed of the detail of the research 
entitled “Effect of Family-Based DOTS Support Program on Adherence to Health 
Behaviors in Patients with Pulmonary Tuberculosis in Indonesia” and was assured 
that no part of my personal information and research result shall be individually 
revealed to the public. If any problem or issues occur, I would discuss with the 
researcher. I have the right to withdraw from this project at any time without any 
effects on any nursing/ medical service and treatment. I am willing to participate in 
this research project voluntarily and hereby endorse my signature. 
 
Given by :…………………………..( Consenter) Date :………………………….. 
 
 
Researcher Note: 
 I gave the detailed information of the research entitled “Effect of Family-
Based DOTS Support Program on Adherence to Health Behaviors in Patients with 
Pulmonary Tuberculosis in Indonesia” to the patient. I provide the opportunity to the 
patient to ask any question and provide the required answer. 
 
Signature : ………………………….. (Researcher) 
Date : …………………………. 
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Appendix E 
Family-Based DOTS Support Program 
 
The program consists of four main activities: 1) estimative operation; 2) transitive 
operation; 3) productive operation; & 4) follow-up. Those activities were designed 
based on three phases of care operations: estimative, transitive, & productive. The 
estimative operation is done on the same day after the participant has signed the 
consent form. The transitive and productive operations are performed separately 
within three days. The follow-up is composed of two telephone calls and one face to 
face meeting. Telephone call follow-ups are performed during the second and third 
weeks and a face to face meeting is in the fourth week. This program is provided by 
the researcher and at patients’ home. 
1. Estimative operation by helping the client (patient and family) gain understanding 
on overview of TB and health related behaviors. 
Time allocation : 60 minutes 
Method of helping  : Teaching by providing knowledge of TB overview and 
health related behaviors 
Media : Tuberculosis care booklet 
2. Transitive operation by assisting the client (patient and family) to make judgments 
and decisions on care of the patient specifically for each health related behavior of 
TB, i.e., complying with anti TB medication, following healthy diets, performing 
physical exercise, maintaining environmental hygiene, preventing, disease 
transition, and dealing the risk factors of TB. 
Time allocation : 60 minutes 
Methods of helping :  
1. Teaching by providing relevant knowledge for developing each behavior  
2. ………………………………………………………………………………… 
3. ………………………………………………………………………………… 
4. ………………………………………………………………………………… 
Media : Tuberculosis care booklet 
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3. Productive operation by promoting the client to make action plans in order that the 
TB patients are able to perform the required actions to meet care demands for each 
health related behavior of TB  
Time allocation : 30 minutes 
Methods of helping :  
1. Teaching by providing knowledge of the action plans indicators and the 
factors influencing performance and the results. 
2. ………………………………………………………………………………….. 
3. ………………………………………………………………………………….. 
4. …………………………………………………………………………………. 
Media: Tuberculosis care booklet 
4. Follow-up 
Time allocation : Depend on patient’s need (minimum 15 minutes) 
Methods of helping :  
1. Telephone calls (week 2 and week 3)  
Guiding and supporting are two main helping methods used for identifying the 
barriers of implementing the program including supporting and appreciating 
each health behavior done. The reinforcement is given to maintain and 
improve each behavior by identifying the important behaviors done, stating 
directly the behaviors doing well, providing appreciation, and explaining 
clearly consequences of the behaviors. 
 
2. Face to face (week 4) 
Guiding and supporting methods are provided in this follow-up as same as the 
telephone call follow-ups. Providing an environment is given by providing 
opportunities to continue or revise actions plan (i.e., respect and trust, 
conducive to designing and participating, and sufficient resources). 
Media : telephone call and tuberculosis care booklet for face to 
face follow-up (week 4)
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Family-Based DOTS Support Framework 
 
Instruction: 
The program framework is designed based on Orem’s Self-Care Deficit Nursing Theory. This program framework describes wholly activities 
and the sequences that will be started by providing knowledge, decision-making, and designing the action plans for each aspect of care. 
 
N
o 
Aspects of 
Care 
Knowing (Estimative) Decision Making (Transitive) Producing (Productive) 
Nurse Family Patient Nurse Family Patient Nurse Family Patient 
1 TB 
overview 
- Discuss on 
health and TB 
beliefs 
- …………….. 
 
The family 
respond 
actively 
by: 
- paying 
attentio
n to 
explan
ation 
given 
- …….. 
 
The patient 
respond 
actively 
by: 
- paying 
attentio
n to 
explan
ation 
given 
- ……… 
 
- Discuss: 1)  
recent 
symptoms, 
how they 
influence the 
activities, 
and the 
actions taken 
to reduce 
them; 2) 
understandin
g and 
awareness of 
the impacts 
of TB  
 
- …………….. 
 
 
 
 
 
 
- Help give 
explanations 
of recent 
symptoms 
and impacts 
of TB 
 
 
 
 
 
 
 
 
 
 
- …………… 
 
 
 
 
- Share the 
symptoms 
and 
answer the 
questions 
 
 
 
 
 
 
 
 
 
 
 
- …………. 
 
 
 
- Help in 
making 
plans 
related to 
symptoms 
manageme
nt and TB 
impacts 
 
- …………. 
 
 
 
 
 
 
 
- Help the 
patient 
in 
operatin
g the 
action 
plans 
 
 
- ………. 
 
 
 
 
 
 
 
 
- Make the 
actions 
plan 
 
 
 
 
 
 
- ……… 
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N
o 
Aspects of 
Care 
Knowing (Estimative) Decision Making (Transitive) Producing (Productive) 
Nurse Family Patient Nurse Family Patient Nurse Family Patient 
2 TB and 
medications
- Discuss the 
importance of 
TB treatment; 
how TB is 
treated, 
treatment 
regimen and its 
side effects 
- ………………. 
- Ask 
questions 
related to 
conditioning 
factors/ 
barriers of 
medication 
taking, diets, 
exercise, 
healthy 
environment, 
disease 
transmission, 
and TB risk 
factors 
- …………….. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
- Answer 
questions  
 
 
 
 
 
 
 
 
 
 
 
 
 
- ………….  
- Help in 
making 
plans 
related to 
take TB 
medication 
- …………... 
 
 
- Make 
actions 
plan 
with the 
patient 
 
- ……….. 
 
 
- Design 
the 
actions 
plan 
 
   
- ………… 
3 TB and 
diet 
- Discuss 
importance of 
sufficient diet 
for TB patients 
and healthy 
diets for TB 
patients 
- ………………. 
4 TB and 
exercise 
- Discuss 
importance of 
exercise for TB 
patients and 
kinds that can 
be done by TB 
patients 
5 TB and 
Environm
ent 
- Discuss 
importance of 
and how to 
have and 
maintain 
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N
o 
Aspects of 
Care 
Knowing (Estimative) Decision Making (Transitive) Producing (Productive) 
Nurse Family Patient Nurse Family Patient Nurse Family Patient 
healthy 
environment 
   
 
 
 
 
 
 
 
 
6 TB and 
transmissi
on 
- Discuss danger 
of TB as a 
contagious 
disease and 
how to prevent 
the disease 
transmission 
7 TB and 
risk 
factors 
- Discuss risk 
factors of TB 
patient and 
their impacts 
on TB 
treatment and 
recovery; and 
how to deal 
with each risk 
factor 
8 Follow up 
(phone in 
week 2 & 
3) 
-  - - - Reinforce 
positive 
actions and 
ask to 
continue in 
engaging the 
actions 
- …………….. 
- Help the 
patient in 
providing 
explanations 
 
 
 
- …………… 
- Discuss 
the 
implement
ed actions 
and the 
barriers 
 
- …………. 
 
 
- Evaluate  
actions that 
have been 
employed 
 
 
 
 
 
 
- Help in 
explaini
ng what 
has 
been 
done 
and the 
barriers 
 
 
- Explain
s the 
success 
and 
unsucce
ssful 
plans 
and the 
barriers 
of 
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N
o 
Aspects of 
Care 
Knowing (Estimative) Decision Making (Transitive) Producing (Productive) 
Nurse Family Patient Nurse Family Patient Nurse Family Patient 
 
 
 
 
 
 
- …………. 
 
 
 
- ………. 
followi
ng 
plans 
- ………. 
9 Follow up 
(face to 
face in 
week 4) 
-    - Reinforce 
positive 
actions and 
ask to 
continue in 
engaging the 
actions 
- …………….. 
- Help the 
patient in 
providing 
explanations 
 
 
 
- …………… 
- Discuss 
actions 
that have 
been 
implement
ed and the 
barriers 
- …………. 
 
 
 
 
 
 
 
 
 
 
 
 
- Evaluate  
actions that 
have been 
employed 
 
 
 
 
 
 
- …………... 
- Help in 
explaini
ng what 
has 
been 
done 
and the 
barriers 
 
 
- ………. 
- Explain
s the 
success 
plans 
and the 
barriers 
of 
followi
ng 
plans 
- ………. 
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1. Teaching Plan (Guideline) for Estimative Phase (Knowing)  
 
Instruction: 
The first session is started using the teaching technique for the estimation phase. Each aspect of care is explained to both the patient and the 
family. However, the teaching technique is also used for transitive (decision making) and operative (design actions plan) phases if needed to re-
explain and remind the patient/ family. 
 
 
No Topic Objectives Content 
Method/ 
Media/ 
Time 
Activities Evaluation 
The 
Researcher 
The Patient 
and the Family 
1. Introduction  - This intervention is started by providing 
knowledge and discussing TB and health 
behaviors.  
- ……………………………………... 
Discussion/  
6 minutes 
- Explains the 
topics 
clearly 
- …………… 
 
- Listen 
carefully 
- ……………. 
 
- 
2 Overview of 
TB  
After completing 
this session, 
patient and 
family are able 
to: 
- Have the 
appropriate 
belief of TB 
- …………… 
 
- TB disease 
 Tuberculosis (TB) is a disease caused 
by germs that are spread from person 
to person through the air.  
 …………………………………...  
 Clarify health belief of TB 
- TB is serious disease that may 
kill you but you can be cured if 
you take all medications 
completely and correctly. 
- ……………………………… 
- …………………………………………... 
 …………………………………….  
Discussion/ 
TB care 
Booklet, 
Flipchart/ 6 
minutes 
- Family 
and 
patient  
participa
tion in 
discussio
n 
3 TB and 
medications 
After completing 
this session, 
patient and 
- The importance of TB treatment 
The medications are essential to eradicate 
the germs. Good medication taking 
Discussion/ 
TB care 
Booklet, 
Family and 
patient  
participation 
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No Topic Objectives Content 
Method/ 
Media/ 
Time 
Activities Evaluation 
The 
Researcher 
The Patient 
and the Family 
family are able 
to: 
- State the 
importance of 
TB treatment 
correctly 
- …………….. 
 
 
behaviors will prevent the possible failure 
of treatment and drug resistance 
- …………………………………………... 
 
 
 
Flipchart/ 8 
minutes 
in discussion 
4 TB and diets After completing 
this session, 
patient and 
family are able 
to: 
- State the 
importance of 
sufficient diet 
of TB 
correctly 
- ……………. 
- The importance of a sufficient diet for TB 
patients  
Having good nutrition will build 
immunity and make your body fight 
against the TB germs and prevent a 
worsening condition. Therefore, 
weighing routinely is recommended for 
TB patients. The amount of each food can 
be seen in the TB booklet. 
- ………………………………………… 
 
Discussion/ 
TB care 
Booklet, 
Flipchart/ 8 
minutes 
Family and 
patient  
participation 
in discussion 
5 TB and 
exercise 
After completing 
this session, 
patient and 
family are able 
to: 
- State the 
importance of 
exercise for 
- The importance of exercise for TB 
patients  
Exercise helps you to maintain the health  
- …………………………………………... 
 
Discussion/ 
TB care 
Booklet, 
Flipchart/ 8 
minutes 
Family and 
patient  
participation 
in discussion 
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No Topic Objectives Content 
Method/ 
Media/ 
Time 
Activities Evaluation 
The 
Researcher 
The Patient 
and the Family 
TB patient 
correctly 
- ……………. 
6 TB and 
environmental 
After completing 
this session, 
patient and 
family are able 
to: 
- State the 
importance of 
environment 
for TB patient 
correctly 
- …………….. 
- The importance of environment for TB 
patients 
Environment helps provide conducive 
conditions for patient during treatment 
and preventing TB transmission. In 
addition, environment plays an important 
role in disease recovery. In addition, 
management of sputum disposal is 
needed. It can be seen in the TB booklet. 
 
- …………………………………………
…. 
Discussion/ 
TB care 
Booklet, 
Flipchart/ 8 
minutes 
Family and 
patient  
participation 
in discussion 
7 TB and 
transmission 
After completing 
this session, 
patient and 
family are able 
to: 
- State the 
danger of 
contagious of 
TB correctly  
- ……………... 
- The dangers of TB as a contagious 
disease  
TB can spread to others by coughing, 
sneezing, speaking or singing. The germs 
can stay in the air for several hours and 
depend on the environment 
- ………………………………………...… 
Discussion/ 
TB care 
Booklet, 
Flipchart/ 8 
minutes 
Family and 
patient  
participation 
in discussion 
8 TB and risk 
factors 
After completing 
this session, 
patient and 
- The risk factors of TB disease that can 
make you get worse germs and become 
sick with the disease are: 
Discussion/ 
TB care 
Booklet, 
Family and 
patient  
participation 
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No Topic Objectives Content 
Method/ 
Media/ 
Time 
Activities Evaluation 
The 
Researcher 
The Patient 
and the Family 
family are able 
to: 
- State at least 
3 of 5 risk 
factors of TB 
disease 
• Smoking cigarettes 
• Drink alcohol 
• Using injection drug 
- ………………………………………… 
 
Flipchart/ 8 
minutes 
in discussion 
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2. Questions Guideline for Transitive Phase (Decision Making) 
 
Instruction: 
Transition phase aims to help in decision making for each aspect of care.  Situations probably occur in the order that selected questions 
are required to consider the decision. In addition, the patient and family are helped by providing any alternatives in terms of benefits and 
costs of each alternative. 
 
No Aspects Questions 
1 TB overview - Please inform me of your recent complaints (signs of TB)? 
- ……………………………………………………………………………………………………… 
2 TB and medications - Please tell me how you have coped with your medication so far? 
- ……………………………………………………………………………………………………..  
3 TB and diets - Please compare your present diets and the expected diets for TB patients as explained in the 
previous session! 
- ………………………………………………………………………………………………………  
4 TB and exercise - What do you think about your exercise so far? 
- ………………………………………………………………………………………………………... 
5 TB and environment - What do you think of your environment? Does it help you during TB treatment? 
- ……………………………………………………………………………………………………… 
6 TB and transmission - What have done for preventing transmission? 
- ………………………………………………………………………………………………………..
. 
7 TB and risk factors - What are the factors that you cannot avoid? Why? 
- ……………………………………………………………………………………………………….. 
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Transitive Operation Phase 
Decisional Balance sheet 
 
Instruction: 
This sheet is used to help the patient and family for each alternative in the decision making process. Pros refer to the advantages and cons refer 
to the disadvantages of chosen alternatives. 
 
Health Behaviors Continuing Behaviors 
Pros (Benefits) Cons (costs) 
Complying to anti medications  
 
 
Following healthy diets  
 
 
Performing physical exercise  
 
 
Maintaining healthy environment  
 
 
Preventing disease transmission  
 
 
Dealing with the risk factors  
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3. Action Plan and Implementation Form of Family-Based DOTS Support Program for Productive Phase 
 
Instruction: 
This form is used to design an action plan. The researcher helps the patients and their families in this phase.  The form is filled in by the 
researcher and if the patients/ families would like to fill it in, they are allowed. 
Please fill in this form based on your abilities to perform health behaviors. 
1. Set the goal for each behavior 
2. State activities/ actions for each behavior 
3. Explain how the activities will be implemented in terms of what, when, frequency, and how 
 
No Aspects of Care Planning Actions Evaluation 
1 Complying with anti TB 
medications 
Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally complying with anti TB 
medications 
- Some behaviors have changed 
- No behaviors have changed at all 
- Barriers: 
1. 
2. 
2 Following healthy diets Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally following healthy diets 
- Some behaviors have changed 
- No behaviors have changed at all 
- Barriers: 
1. 
2. 
3 Performing physical 
exercise 
Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally performing physical 
exercise 
- Some behaviors have changed 
- No behaviors have changed at all 
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No Aspects of Care Planning Actions Evaluation 
- Barriers: 
1. 
2. 
4 Maintaining 
environmental hygiene 
Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally maintaining 
environmental hygiene 
- Some behaviors have changed 
- No behaviors have changed at all 
- Barriers: 
1. 
2. 
5 Preventing disease 
transmission 
Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally preventing disease 
transmission 
- Some behaviors have changed 
- No behaviors have changed at all 
- Barriers: 
1. 
6 Dealing with the risk 
factors of TB 
Goals: 
 
What: 
When: 
Frequency: 
How: 
Evaluation 
- Totally avoiding the risk factors 
of TB 
- Some behaviors have changed 
- No behaviors have changed at all 
- Barriers: 
1. 
2. 
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Appendix F 
Tuberculosis Care Booklet 
 
168 
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Appendix G 
Demographic Data Form 
 
 No Respondent : 
 Date and Time : 
 Phone Number : 
 
The following items are some information about yourself. Please fill and answer by 
putting (√) mark in the square box that is appropriate to you. 
A. Patient Information 
1. Age …………  years  
2. Gender (1) Male (2) Female 
… 
 
B. Health Related Data 
1. Medications of TB 
Length of treatment :  days 
Medications taken :       tablets/ day 
 
Demographic Data Form filled by the Researcher 
 
1. General condition 
Body weight : Kg 
Height : cm 
BMI : kg/m2 
 
2. ………………………………………………………….. 
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Demographic Data Form for Family 
 No Respondent : 
 Date and Time : 
 
The following items are some information about your family. Please fill and answer 
by putting (√) mark in the square box that is appropriate to you. 
a. Family history of caring for TB patients:    (1) Yes  (2) 
No 
b. Family history caring for chronic disease patients:   (1) Yes (2) 
No 
c. Family members with chronic disease:   (1) Yes , specify  (2) 
No 
d. Family Type  (1) Nuclear   (2) Extended 
Other, please identify: 
e. Family size:   persons 
f. People living in the household with the patient (you can choose more than one) 
Children less than five years old 
Elderly 
Pregnant women 
Others, specify: 
g. Environmental health 
Cleanliness of house : (1) good (2) moderate  (3) poor 
Sufficient ventilation : (1) good (2) moderate (3) 
poor 
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Demographic Data Form for DOTS Observer 
 No Respondent : 
 Date and Time : 
 Phone Number : 
 
The following items are some information about yourself. Please fill and answer by 
putting (√) mark in the square box that is appropriate to you. 
a. Age:   years 
b. Gender   (1) Male  (2) Female 
c. Marital status  (1) Married  (2) Single 
(3) Divorce  (4) others, specify: 
4. Religion:   (1) Islam  (2) Christian  
   (3) Catholic  (4) Buddhist 
   (5) Hindu 
5. Occupation  (1) None    (2) Farmer 
   (3) Government employee  (4) Private employee 
   (5) Business    (6) other, please identify: 
6. Level of education 
(1) No schooling   (2) Elementary school 
    (3) Junior high school   (4) Senior high school 
    (5) College or above 
7. Caregiver during treatment: 
   (1) Father and/ or mother  (2) Brother/ Sister 
(3) Spouse (husband/ wife)  (4) Son/ daughter 
(5) Other, specify: 
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Appendix H 
Adherence to Health behaviors Questionnaire 
 
 No Respondent : 
 Date and Time : 
This questionnaire is about your health behaviors during this past week. Please 
select one of four choices (all the time, most of the time, sometime, and never) that 
you performed during TB treatment. Please respond to each item as accurately as 
possible and do not skip any items.  Please put a mark (√) next to the item you have 
selected. 
All the time : every day 
Most of the time : 5-6 days 
Sometime : 1-4 days 
Never :  not done 
 
No Statements 
A
ll 
th
e 
tim
e 
(4
) 
M
os
t o
f t
he
 ti
m
e 
(3
) 
So
m
et
im
e 
(2
) 
N
ev
er
 (1
) 
Complying with Anti TB Medication     
1 I take anti TB medication regularly     
2 I take anti TB medications timely as prescribed by the 
doctor 
    
3 ………………………………………………………………     
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Appendix I 
Means and Standard Deviations of Each Dimension of the Adherence to Health behaviors Questionnaire 
 
Table 
Pretest and Posttest Means and Standard Deviations of Each Dimension of Adherence to Health Behaviors in the Experimental and 
Control Group (N= 60) 
No Statements 
Experimental Group Control Group 
Pretest Posttest Pretest Posttest 
M SD M SD M SD M SD 
Complying with Anti TB Medication 
1 I take anti TB medication regularly 3.83 .46 3.83 .38 3.97 1.83 3.77 .43 
2 I take anti TB medications timely as prescribed 
by the doctor 
3.57 .63 3.73 .45 3.93 .25 3.50 .57 
3 ………………………………………………….         
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Appendix J 
List of Experts 
 
 Three experts examine the construct and cultural applicability for the Family-
Based DOTS Support Program and Adherence to Health Questionnaire, they 
were: 
1. Dr. Piyanuch Jittanoon 
Assistant Professor, Prince of Songkla University, Thailand 
2. Dr. Petchawan Pungrassami 
Tuberculosis Practitioner and Director of Tuberculosis Center in Yala 
Province   
3. Neti Juniarti, S.Kp., M.Kes., M.Ng. 
Nursing Lecturer, Unversitas Padjadjaran, Thailand 
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